Musculoskeletal and Neural Physiological Phenomena – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Wed, 01 Jul 2026 08:57:48 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Musculoskeletal and Neural Physiological Phenomena – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Zoledronic Acid Monohydrate https://clinicaltrials.eu/drug/zoledronic-acid-monohydrate/ Wed, 01 Jul 2026 08:57:48 +0000 https://clinicaltrials.eu/drug/zoledronic-acid-monohydrate/ Zoledronic Acid Monohydrate: A Comprehensive Guide for Patients

Table of Contents

What is Zoledronic Acid Monohydrate?

Zoledronic Acid Monohydrate is a medication that belongs to a class of drugs called bisphosphonates[1]. It is commonly known by its brand names such as Zometa, Reclast, or Aclasta. This medication is primarily used to treat bone-related conditions and certain types of cancer that affect the bones.

Medical Uses

Zoledronic Acid Monohydrate is used to treat several medical conditions, including:

  • Osteoporosis: A condition where bones become weak and brittle, increasing the risk of fractures[1]
  • Bone metastases: Cancer that has spread to the bones from other parts of the body[2]
  • Multiple myeloma: A type of blood cancer that affects plasma cells and can cause bone damage
  • Paget’s disease of bone: A disorder that causes abnormal bone growth and deformity
  • Hypercalcemia: High levels of calcium in the blood, often associated with cancer

How It Works

Zoledronic Acid Monohydrate works by slowing down the process of bone breakdown in the body. It does this by:

  • Inhibiting the activity of cells called osteoclasts, which are responsible for breaking down bone tissue
  • Promoting the formation of new bone
  • Increasing bone density and strength

By reducing bone breakdown and promoting bone formation, Zoledronic Acid Monohydrate helps to maintain stronger bones and reduce the risk of fractures[1].

Administration

Zoledronic Acid Monohydrate is typically administered as an intravenous (IV) infusion. This means it is given directly into a vein through a needle or catheter. The infusion usually takes about 15 to 30 minutes[1][2].

Dosage

The dosage of Zoledronic Acid Monohydrate can vary depending on the condition being treated and the patient’s individual needs. Some common dosages include:

  • For osteoporosis: 5 mg once a year
  • For bone metastases: 4 mg every 3 to 4 weeks
  • For Paget’s disease: A single dose of 5 mg

It’s important to note that these are general guidelines, and your doctor will determine the appropriate dosage for your specific situation[1][2].

Side Effects and Precautions

Like all medications, Zoledronic Acid Monohydrate can cause side effects. Some common side effects include:

  • Flu-like symptoms (fever, chills, body aches)
  • Fatigue
  • Bone, joint, or muscle pain
  • Nausea or vomiting
  • Headache

More serious side effects, though rare, can include:

  • Osteonecrosis of the jaw: A condition where the jawbone tissue dies, potentially causing pain and infection
  • Atypical femur fractures: Unusual fractures of the thighbone
  • Kidney problems: Especially in patients with pre-existing kidney issues

It’s crucial to inform your doctor about any pre-existing medical conditions, especially kidney problems or dental issues, before starting treatment with Zoledronic Acid Monohydrate[1][2].

Ongoing Research

Researchers are continuously studying Zoledronic Acid Monohydrate to explore its potential benefits in various medical conditions. Some ongoing areas of research include:

  • Osteosarcoma treatment: A study is investigating the use of Zoledronic Acid in combination with chemotherapy and surgery for treating high-grade osteosarcoma in children, adolescents, and adults[3].
  • Post-denosumab discontinuation: Researchers are studying the effectiveness of Zoledronic Acid treatment strategies after stopping denosumab (another bone-modifying drug) in postmenopausal women with osteoporosis[4].
  • Vertebral metastases treatment: A study is evaluating the efficacy of adding Zoledronic Acid to stereotactic radiotherapy in the treatment of vertebral metastases[5].
  • Knee implant stability: Researchers are investigating whether topical application of Zoledronic Acid can improve the stability of knee implants in patients with osteoarthritis undergoing total knee arthroplasty[6].

These ongoing studies may provide new insights into the potential uses and benefits of Zoledronic Acid Monohydrate in various medical conditions.

]]> Vosoritide https://clinicaltrials.eu/drug/vosoritide/ Wed, 01 Jul 2026 08:57:44 +0000 https://clinicaltrials.eu/drug/vosoritide/ Vosoritide Clinical Trials in Children With Growth Conditions

Table of Contents

Clinical trials overview

The trial data show that Vosoritide is being studied in children with several growth conditions, which are health conditions linked to short height or slower growth.[1] The studies are looking at both safety and possible benefit for growth, which means researchers want to know whether the treatment can be used over time and whether it may help children grow better.[1][2]

These trials include children with achondroplasia, hypochondroplasia, Turner syndrome, short stature homeobox-containing gene deficiency, Noonan syndrome, and idiopathic short stature.[1][2][3][4]

Conditions being studied

Achondroplasia is studied in two trials, including a long-term study in children and a later comparison study against BMN 333.[1][5]

Hypochondroplasia is studied in three trials: one Phase 3 study in children, one Phase 2 study in infants and young children aged 0 to less than 36 months, and one long-term extension study.[2][3][4]

Two other trials study children with Turner syndrome, short stature homeobox-containing gene deficiency, and Noonan syndrome, or children with idiopathic short stature.[6][7]

Trial designs and phases

The studies use different trial designs, including randomized, double-blind, and placebo-controlled designs.[2][3][6] Randomized means children are put into groups by chance. Double-blind means neither the family nor the study team knows who gets which treatment during the trial. Placebo-controlled means some participants receive a look-alike treatment with no active study drug, so results can be compared fairly.

The trial phases range from Phase 2 to Phase 4.[1][2][4][5][6][7][8] Phase 2 trials in this set look at early safety and growth effects, while Phase 3 trials test the treatment in larger groups and Phase 4 studies look at later comparisons or follow-up.[2][4][5][8]

What the trials measure

The main growth outcome in several studies is annualized growth velocity (AGV), which means how much a child grows in one year.[2][3][6][7][8] Some trials measure change from baseline, which means they compare results with the starting point before treatment began.[2][3][6][7][8]

Other important outcomes include height Z-score, height, and the upper-to-lower body segment ratio.[3][4][5] The height Z-score shows how a child’s height compares with other children of the same age and sex. The upper-to-lower body segment ratio helps researchers understand body proportions, which is important in some growth conditions.

Safety outcomes are also important. Researchers track adverse events, serious adverse events, laboratory tests, vital signs, physical examination findings, electrocardiograms, echocardiograms, imaging, and clinical hip assessment in some studies.[1][3][5] Adverse events are unwanted medical problems that happen during a study, and serious adverse events are more serious problems that may need special care.

Who may take part

The studies are designed for children, not adults, and the age groups vary by trial.[1][3][6][7] One hypochondroplasia study includes infants and young children from birth to under 36 months.[3] Other studies include children with specific growth conditions such as achondroplasia, Turner syndrome, SHOX deficiency, Noonan syndrome, or idiopathic short stature.[1][2][5][6][7]

Some trials compare Vosoritide with placebo, while others compare it with another treatment approach or continue treatment over a longer time.[2][3][4][6][7][8]

Long-term follow-up studies

Several trials are long-term extension studies, which means they follow children after the first part of the study ends.[1][4][5] These studies are important because they look at treatment effects over time, including until final adult height, which is the height a person reaches when growth is finished.[4]

The long-term studies in achondroplasia and hypochondroplasia track both growth and safety, including treatment-emergent adverse events and yearly changes in height measures.[1][4][5]

Summary of the main trials

The completed trials include a Phase 2 study in achondroplasia and a Phase 3 study in hypochondroplasia.[1][2] The authorised trials include Phase 2 and Phase 3 studies in hypochondroplasia, a Phase 3 extension study in achondroplasia, a Phase 2 basket study in Turner syndrome, SHOX deficiency, and Noonan syndrome, a Phase 2 study in idiopathic short stature, and a Phase 4 comparison study in achondroplasia.[3][4][5][6][7][8]

Across the studies, the main research questions are whether Vosoritide can improve growth, how its effects compare with placebo or other treatments, and how safe and tolerable it is during short-term and long-term use.[1][2][3][4][5][6][7][8]

]]> Vancomycin https://clinicaltrials.eu/drug/vancomycin/ Wed, 01 Jul 2026 08:57:41 +0000 https://clinicaltrials.eu/drug/vancomycin/ Vancomycin Clinical Trials: Safety, Efficacy, and Patient Groups Studied

Table of Contents

Clinical trials overview

These studies investigate Vancomycin in many different research settings, mostly for infections and infection prevention.[1][2] The trials ask questions about whether Vancomycin works, how safe it is in the study setting, and how it compares with other treatments or placebo.[3][4]

Some studies use Vancomycin alone, while others use it together with other antibiotics or as part of a larger treatment strategy.[5][6] A few trials also study Vancomycin in prevention settings, such as before surgery or during transplantation care.[7][8]

Conditions and patient groups

The trial data include people with Staphylococcus aureus bacteremia, which means bacteria are present in the blood.[9] Other studies involve periprosthetic joint infection, pyogenic vertebral osteomyelitis (bone infection in the spine), pleural infections, and infections linked to surgery or implanted material.[10][11][12]

Vancomycin is also studied in people with Clostridioides difficile infection, primary sclerosing cholangitis, active ulcerative colitis, and patients with resistant bacteria such as VRE and MDR Enterobacteriaceae.[13][14][15] The target groups include adults, children, critically ill patients, surgical patients, and patients hospitalized for stem cell transplantation.[16][17]

Trial phases and study designs

The studies cover Phase 1, Phase 2, Phase 3, and one low-intervention trial.[18] Phase 1 studies in the source data focus on drug levels in cerebrospinal fluid or early safety and feasibility in children.[19][20]

Phase 2 trials look at early effectiveness, safety, and biological effects, such as recurrence of infection, drug response, or changes in the gut microbiome.[21][22] Phase 3 trials are larger and often compare Vancomycin with standard care, placebo, or another treatment to test whether one approach is non-inferior, meaning not worse than the other by a set margin.[23][24]

What is being measured

The main outcomes include clinical cure, recurrence, treatment failure, and mortality.[25][26] Some trials also measure whether patients need more antibiotics, surgery, or hospital readmission after the first treatment period.[27][28]

Several studies measure drug levels in blood or cerebrospinal fluid, which helps researchers understand exposure to the treatment in the body.[29][30] Other endpoints include quality of life, health costs, microbiome changes, and laboratory measures such as ALP, which is alkaline phosphatase, a liver-related blood test used in one study.[31][32]

Selected trials with Vancomycin

NCT05137119 is a large Phase 3 platform trial in patients with Staphylococcus aureus bacteremia. It measures all-cause mortality at 90 days and includes Vancomycin among several treatment options.[9]

2023-507617-96-01 studies pyogenic vertebral osteomyelitis and asks whether early switch to oral antibiotics after one week of IV treatment is non-inferior to longer IV treatment. Vancomycin is one of the IV options in the study.[10]

NCT05256693 tests oral Vancomycin to prevent Clostridioides difficile infection in people hospitalized for allogeneic hematopoietic stem cell transplantation, with infection during hospitalization as the main outcome.[13]

NCT05876182 compares oral Vancomycin with placebo in adults and young patients with Primary Sclerosing Cholangitis, using ALP levels at 6 months as the main endpoint.[14]

NCT04731025 studies local antibiotics, including Vancomycin, in women having implant-based breast reconstruction, with implant loss within 180 days as the main outcome.[33]

2024-515791-12-00 is a completed Phase 1 study in children with external ventricular drain that measured Vancomycin levels in cerebrospinal fluid, including Cmax, tmax, AUC0-τ, and half-life.[19]

What the trial results mean for patients

When a trial measures non-inferiority, it is testing whether a shorter or simpler treatment is not meaningfully worse than the standard approach.[23] This matters in studies of infections where shorter treatment could reduce time in hospital or reduce treatment burden if the results are good enough.[24]

When a study looks at microbiome changes, it is studying how treatment may affect the normal germs in the gut.[15] When it measures quality of life or QALYs, it is trying to understand how treatment affects daily life and overall health value, not only infection control.[31]

Overall, the trial program shows that Vancomycin is being studied across many different patient groups, from children to adults, and across both treatment and prevention settings.[1][16] The main focus is whether it helps control infection, prevent recurrence, and do so with acceptable safety and practical benefit.[3][25]

]]> Tobramycin https://clinicaltrials.eu/drug/tobramycin/ Wed, 01 Jul 2026 08:57:33 +0000 https://clinicaltrials.eu/drug/tobramycin/ TOBRAMYCIN: A Comprehensive Guide for Patients

Table of Contents

What is Tobramycin?

Tobramycin is an antibiotic medication primarily used to treat certain bacterial infections, particularly those caused by Pseudomonas aeruginosa. This bacterium is known to cause serious lung infections in people with certain chronic respiratory conditions[1]. Tobramycin belongs to a class of antibiotics called aminoglycosides, which work by killing bacteria or preventing their growth[2].

Tobramycin is available under various brand names, including:

  • TOBI
  • Bramitob
  • Bethkis
  • Tobrineb
  • Actitob
  • Vantobra
  • Nebcinal

What Conditions Does Tobramycin Treat?

Tobramycin is primarily used to treat the following conditions:

  1. Cystic Fibrosis (CF): This is a genetic disorder that affects the lungs and other organs. Tobramycin is commonly used to treat chronic lung infections caused by Pseudomonas aeruginosa in CF patients[1].
  2. Non-Cystic Fibrosis Bronchiectasis: This is a condition where the airways of the lungs become abnormally widened, leading to a build-up of excess mucus. Tobramycin can be used to treat Pseudomonas aeruginosa infections in these patients[3].
  3. Other Pseudomonas aeruginosa Infections: Tobramycin may be used to treat various other infections caused by this bacterium, particularly in the lungs[4].

How is Tobramycin Administered?

Tobramycin is typically administered through inhalation, allowing it to reach the lungs directly. There are several ways to inhale tobramycin:

  1. Nebulizer Solution: This is a liquid form of tobramycin that is turned into a mist by a machine called a nebulizer. The mist is then inhaled through a mask or mouthpiece[1].
  2. Dry Powder Inhaler: This is a device that delivers tobramycin as a dry powder. Examples include the TOBI Podhaler and the Cyclops device[5][3].
  3. Soft Mist Inhaler: This is a newer type of device that creates a fine mist of medication without using propellants[4].

Effectiveness of Tobramycin

Tobramycin has been shown to be effective in treating Pseudomonas aeruginosa infections in patients with cystic fibrosis and non-CF bronchiectasis. It can help:

  • Improve lung function[1]
  • Reduce the density of Pseudomonas aeruginosa in the lungs[6]
  • Decrease the frequency of hospitalizations[7]
  • Improve quality of life[7]

Dosage and Administration

The dosage and administration of tobramycin can vary depending on the specific product and the patient’s condition. However, some common regimens include:

  • 300 mg twice daily for 28 days, followed by 28 days off treatment[1]
  • 170 mg twice daily[8]
  • 112 mg (4 x 28 mg capsules) twice daily for dry powder inhalers[9]

It’s important to note that the dosage should always be determined by a healthcare professional based on individual patient factors.

Potential Side Effects

While tobramycin is generally well-tolerated, it can cause some side effects. Common side effects may include:

  • Cough
  • Wheezing
  • Shortness of breath
  • Throat irritation
  • Changes in voice

In rare cases, tobramycin may cause more serious side effects such as hearing loss or kidney problems. It’s important to report any unusual symptoms to your healthcare provider[3][7].

Ongoing Research

Research on tobramycin is ongoing, with studies focusing on:

  • New delivery methods to improve efficiency and ease of use[5][9]
  • Different dosing regimens to optimize treatment[6]
  • Use in non-CF bronchiectasis patients[7]
  • Comparison of different tobramycin products[8]

These studies aim to improve the effectiveness of tobramycin treatment and expand its use to benefit more patients with chronic lung infections.

]]> Thiamine Hydrochloride https://clinicaltrials.eu/drug/thiamine-hydrochloride/ Wed, 01 Jul 2026 08:57:30 +0000 https://clinicaltrials.eu/drug/thiamine-hydrochloride/ Thiamine Hydrochloride: A Comprehensive Guide for Patients

Table of Contents

What is Thiamine Hydrochloride?

Thiamine Hydrochloride, also known as Vitamin B1, is an essential nutrient that plays a crucial role in various bodily functions. It’s a water-soluble vitamin that helps convert food into energy and is vital for the proper functioning of the heart, nerves, and brain[1]. Thiamine Hydrochloride is the form of thiamine commonly used in medical treatments and supplements.

This vitamin is also known by several other names, including:[1]

  • Thiamine Chloride
  • Aneurine Hydrochloride
  • B Complex Vitamin

Medical Uses of Thiamine Hydrochloride

Thiamine Hydrochloride is used to treat or prevent various medical conditions, including:

  1. Wernicke-Korsakoff Syndrome (WKS): This is a brain disorder often associated with alcohol dependence. Thiamine deficiency is the primary cause of WKS, and thiamine supplementation is a crucial part of its treatment[1].
  2. Heart Failure: Some studies have shown that thiamine supplementation may improve heart function in patients with chronic heart failure[2].
  3. Septic Shock: Research is being conducted to investigate whether thiamine can help protect kidney function in patients with septic shock, a severe condition where infection leads to dangerously low blood pressure[3].
  4. Thiamine Deficiency in Various Conditions: Thiamine supplementation is used to treat deficiency in conditions such as obesity[4], alcohol dependence[1], and after certain types of surgery[5].
  5. Congenital Heart Diseases: Research is being conducted on the potential benefits of thiamine in children with certain types of congenital heart defects[6].

How Thiamine Hydrochloride is Administered

Thiamine Hydrochloride can be administered in several ways, depending on the condition being treated and its severity:

  • Oral Tablets: For less severe cases or preventive measures, thiamine may be given as oral tablets. Dosages can range from 3-5 mg per day for mild cases up to 300 mg per day for more severe conditions[1][2].
  • Intravenous (IV) Injection: In more severe cases or when rapid treatment is needed, thiamine may be given intravenously. Doses can range from 100 mg to 1500 mg per day, depending on the condition[1][5].
  • Intramuscular (IM) Injection: In some cases, thiamine may be administered via intramuscular injection[1].

The duration of treatment can vary widely, from a few days to several weeks, depending on the condition being treated and the patient’s response to therapy.

Current Research on Thiamine Hydrochloride

Ongoing research is exploring new potential uses for thiamine hydrochloride:

  • Prevention of Delirium: A study is investigating whether high-dose intravenous thiamine can prevent delirium in patients undergoing stem cell transplantation[5].
  • Cardiovascular Function in Hyperthyroidism: Researchers are studying if thiamine supplementation can improve cardiovascular function in patients with severe hyperthyroidism[7].
  • Congenital Heart Defects: A study is examining the role of thiamine in improving heart function after certain procedures in children with congenital heart defects[6].

Potential Side Effects and Precautions

Thiamine Hydrochloride is generally considered safe when used as directed. However, as with any medication, there can be potential side effects:

  • Allergic Reactions: In rare cases, some individuals may experience allergic reactions to thiamine, which can include rash, itching, or difficulty breathing.
  • Upset Stomach: Some people may experience mild stomach upset when taking oral thiamine supplements.

It’s important to note that these side effects are generally rare, especially when thiamine is given in appropriate doses. Always consult with your healthcare provider before starting any new supplement or medication regimen.

]]> Teriparatide https://clinicaltrials.eu/drug/teriparatide/ Wed, 01 Jul 2026 08:57:28 +0000 https://clinicaltrials.eu/drug/teriparatide/ TERIPARATIDE: A Comprehensive Guide for Patients

Table of Contents

What is Teriparatide?

Teriparatide is a medication used primarily for treating osteoporosis, a condition characterized by weak and fragile bones. It’s known by several names, including FORTEO, FORSTEO, and LY333334[1]. Teriparatide is unique among osteoporosis treatments because it’s the only drug that promotes the formation of new bone, rather than just preventing bone loss[2].

Teriparatide is actually a portion of the human parathyroid hormone (PTH). It’s created using recombinant DNA technology, which means it’s produced in a laboratory using genetic engineering techniques[3].

How Teriparatide Works

Unlike other osteoporosis medications that primarily prevent bone loss, teriparatide works by stimulating new bone formation. It does this by increasing the activity of osteoblasts, the cells responsible for building new bone[4]. This unique mechanism of action makes teriparatide particularly effective for people with severe osteoporosis or those at high risk of fractures.

When you take teriparatide, it increases the rate of bone formation, leading to increased bone mineral density (BMD). BMD is a measure of how much calcium and other minerals are present in a segment of bone. Higher BMD generally indicates stronger bones[1].

Conditions Treated with Teriparatide

Teriparatide is primarily used to treat:

  • Postmenopausal Osteoporosis: This is the most common use of teriparatide. It’s prescribed for women who have gone through menopause and are at high risk of bone fractures[3].
  • Osteoporosis in Men: Teriparatide is also approved for use in men with osteoporosis who are at high risk of fracture[4].
  • Glucocorticoid-Induced Osteoporosis: This is osteoporosis caused by long-term use of steroid medications like prednisone[5].

In some cases, teriparatide is also being studied for its potential to speed up the healing of fractures, particularly in older adults[6].

How Teriparatide is Administered

Teriparatide is typically administered as a daily injection under the skin (subcutaneous injection). The standard dose is 20 micrograms per day[3]. It’s usually prescribed for up to 24 months, as prolonged use may increase the risk of developing bone cancer (osteosarcoma) in animal studies, although this hasn’t been observed in humans[1].

Researchers are also exploring alternative methods of administration, including:

  • Nasal Spray: Some studies are investigating the possibility of delivering teriparatide through a nasal spray, which could be more convenient for patients[2].
  • Transdermal Patch: Another potential method being studied is a skin patch that would deliver the medication through the skin[7].

Effectiveness of Teriparatide

Teriparatide has been shown to be highly effective in treating osteoporosis and reducing the risk of fractures. Studies have demonstrated that it can:

  • Increase bone mineral density, particularly in the spine and hip[1].
  • Reduce the risk of vertebral (spine) and non-vertebral fractures[5].
  • Improve bone structure and strength, as measured by advanced imaging techniques[4].
  • Potentially speed up the healing of certain types of fractures[6].

It’s important to note that the effectiveness of teriparatide can vary from person to person, and your doctor will monitor your progress throughout the treatment.

Potential Side Effects

Like all medications, teriparatide can cause side effects. Common side effects may include:

  • Nausea
  • Dizziness
  • Leg cramps
  • Joint pain

Some patients may experience a temporary increase in blood calcium levels after injection. This is usually not harmful but should be monitored by your doctor[8].

As mentioned earlier, long-term use of teriparatide (beyond 2 years) is not recommended due to a potential risk of osteosarcoma observed in animal studies[1].

Ongoing Research and Future Developments

Researchers continue to study teriparatide to better understand its effects and explore new applications. Some areas of ongoing research include:

  • Fracture Healing: Studies are investigating whether teriparatide can speed up the healing of certain types of fractures, particularly in older adults[6].
  • Alternative Delivery Methods: As mentioned earlier, researchers are exploring nasal sprays and skin patches as potential alternatives to daily injections[2][7].
  • Combination Therapies: Some studies are looking at how teriparatide works when combined with other osteoporosis medications[9].
  • Long-term Effects: Researchers are studying the long-term effects of teriparatide treatment, including what happens after patients stop taking the medication[4].

These ongoing studies may lead to new uses for teriparatide or improvements in how it’s administered, potentially making it even more effective and convenient for patients in the future.

]]> Sodium Sulfate Anhydrous https://clinicaltrials.eu/drug/sodium-sulfate-anhydrous/ Wed, 01 Jul 2026 08:57:21 +0000 https://clinicaltrials.eu/drug/sodium-sulfate-anhydrous/ Sodium Sulfate Anhydrous Clinical Trials: What the Studies Are Looking At

Table of contents

Trial overview

The trial data provided here include studies that use Sodium Sulfate Anhydrous in bowel preparation and digestive research settings.[1] The main focus is not on the substance itself, but on how well the preparation works for tests such as colonoscopy, capsule endoscopy, and other digestive procedures.[1]

Several studies compare one preparation with another, while others test how a preparation affects the quality of a medical exam or a clinical outcome.[1][2] The studies are spread across different patient groups and different disease areas.[1][3]

Who is being studied

The target populations are varied. Some trials include people scheduled for elective colonoscopy or colorectal cancer screening, while others include patients with Crohn’s disease, fecal incontinence, hip fracture, recurrent urinary tract infections, axial spondyloarthritis, or major poisoning in intensive care.[1][2][3]

One study focuses on patients with unresectable hepatocellular carcinoma, which means liver cancer that cannot be removed by surgery.[4] Another study looks at patients undergoing small bowel capsule endoscopy, and one study evaluates people after intra-rectal botulinum toxin injections for fecal incontinence.[5][6]

What the trials measure

The most common main outcome is bowel cleansing quality, which means how clean the bowel is before or during the test.[1][7] In the capsule endoscopy study, the primary outcome is the degree of small bowel cleansing using an accepted cleansing scale.[1]

In the colonoscopy studies, researchers measure whether cleansing is adequate, often using the BBPS score, which is a standard bowel cleanliness score.[2] In the colorectal cancer screening trial, the main outcome is the adenoma detection rate, meaning the proportion of patients in whom at least one adenoma is found.[7]

Other studies measure different clinical outcomes. For example, one trial measures the time to onset of high amplitude propagative contractions after laxative instillation, and another measures the proportion of patients needing rescue medication after 72 hours after hip surgery.[2][3] The hepatocellular carcinoma study measures both safety, through serious adverse events, and efficacy, through disease control rate at 12 weeks.[4]

The Crohn’s disease ultrasound study measures whether the terminal ileum lumen fills evenly with contrast and whether the bowel wall can be clearly separated from the lumen.[5] The recurrent urinary tract infection study measures the rate of new infection episodes within 180 days after treatment.[6]

Trial phases and study size

Most of the studies are Phase 2 or Phase 3 trials.[1][2][3] Phase 2 trials usually explore whether a strategy works in a smaller group, while Phase 3 trials are larger and compare approaches more fully.

One study is listed as a low-intervention trial, which means the research approach is lighter than a standard intervention study.[1] Enrollment ranges from very small studies, such as 15 or 21 participants, to large studies with 818 participants.[2][4][7]

Key study types and settings

  • Bowel preparation studies are the largest group. These studies look at how well a preparation cleans the bowel before colonoscopy or capsule endoscopy, and whether the cleansing is good enough for the doctor to see the lining clearly.[1][7]

  • Digestive motility research is also included. In the fecal incontinence study, researchers look at bowel movement patterns after rectal treatment and use manometry, a test that measures pressure and muscle activity in the bowel.[2]

  • Disease-specific research appears in Crohn’s disease, axial spondyloarthritis, and hepatocellular carcinoma. These studies use bowel-related preparation or microbiota-related treatment as part of a wider clinical question.[4][5][8]

  • Supportive care studies are also included, such as the hip surgery trial and the intensive care poisoning study, where the goal is to improve bowel management or reduce absorption of toxic substances.[3][9]

Patient-friendly terms

Adenoma detection rate means how often a colonoscopy finds a polyp-like growth that can matter for cancer screening.[7] Recue medication in the hip surgery study means extra treatment needed if the main plan does not work well enough.[3]

RECIST 1.1 is a standard way to judge whether cancer is shrinking, staying stable, or growing.[4] Disease control in that study means complete response, partial response, or stable disease.[4]

High amplitude propagative contractions are strong bowel contractions that move stool forward.[2] Terminal ileum is the last part of the small bowel, and it is a key area in Crohn’s disease imaging.[5]

]]> Sodium Hydrogen Carbonate https://clinicaltrials.eu/drug/sodium-hydrogen-carbonate/ Wed, 01 Jul 2026 08:57:20 +0000 https://clinicaltrials.eu/drug/sodium-hydrogen-carbonate/ Sodium Hydrogen Carbonate Clinical Trials: Study Overview, Phases, and Outcomes

Table of contents

Trial overview

The source data includes one trial that directly studies Sodium Hydrogen Carbonate in critically ill patients with metabolic acidosis and acute kidney injury.[1] It is a Phase 3 interventional study with 660 participants and a primary outcome called major adverse kidney events at 90 days.[1]

Another Phase 3 trial studies oral bicarbonate in pregnant women with induction of labor and looks at whether delivery happens spontaneously or needs operative help.[2] The data also includes several other trials that use bicarbonate-related products or similar names, but they study different conditions and treatments.[3][4][5]

Critical illness, metabolic acidosis, and acute kidney injury

The trial with NCT 2025-523914-10-00 is titled Evaluating the clinical effectiveness of sodium bicarbonate for critically ill patients with metabolic acidosis and acute kidney injury.[1] It is an authorised Phase 3 interventional study with 660 participants.[1]

This study includes patients with metabolic acidosis, critical illness, and acute kidney injury.[1] The intervention list includes Sodium Hydrogen Carbonate given by intravenous perfusion, compared with other infusion solutions.[1]

The main goal is to investigate the effect of Sodium Hydrogen Carbonate on major adverse kidney events (MAKE90) at day 90.[1] MAKE90 is a combined outcome that includes death, need for kidney replacement therapy, or persistent kidney dysfunction by day 90.[1]

Labor and delivery study

The trial with NCT05719467 is a double-blind, randomized, placebo-controlled, four-arm study in pregnant female participants with induction of labor.[2] It is a Phase 3 interventional study with 3,000 participants.[2]

This study evaluates oral bicarbonate and intravenous butylscopolamine bromide to help facilitate spontaneous delivery.[2] The primary outcome is whether delivery is spontaneous or operative, with operative delivery defined as cesarean delivery, vacuum, or forceps.[2]

This trial is important because it studies a common labor outcome in a large group of pregnant participants.[2] The design also includes a placebo tablet, which helps compare the study treatment with no active treatment.[2]

Other trials in the source data

The source data also lists a Phase 3 trial in hand and foot surgery that studies bicarbonate added to local anesthetic protocols under WALANT.[3] Its main outcome is the Quality Of recovery score (QOR 15) at day 1, which measures early recovery after surgery.[3]

Another Phase 3 trial studies bicarbonate for in-hospital cardiac arrest and measures return of spontaneous circulation.[4] This is a very different emergency setting from the kidney and labor studies.[4]

There is also a Phase 3 study in chronic constipation that uses Lecicarbon® and measures tolerability, safety, compliance, and complete spontaneous bowel movements recorded in patient diaries.[5] Although it is related to bicarbonate in the study data, it is a different product and a different condition.[5]

What the trials measure

Trial endpoints are the main results researchers want to measure.[1][2][3][4][5]

  • MAKE90 in the kidney study means a combined kidney outcome measured by day 90.[1] It includes death, dialysis or other kidney replacement therapy, or lasting kidney damage.[1]

  • Spontaneous versus operative delivery in the labor study checks whether birth happens without tools or surgery, or whether cesarean, vacuum, or forceps are needed.[2]

  • QOR 15 in the surgery study measures how well patients recover on day 1 after the operation.[3]

  • Return of spontaneous circulation in the cardiac arrest study checks whether the heart starts beating again on its own.[4]

  • Complete spontaneous bowel movements in the constipation study are used to track treatment safety, tolerability, and compliance in patient diaries.[5]

Patient-friendly explanation of key terms

Phase 3 means the treatment is being tested in a larger group of people, often to compare it with standard care or placebo.[1][2][3][4][5]

Interventional means the researchers assign a treatment and watch what happens.[1][2][3][4][5]

Randomized means people are placed into study groups by chance, which helps make the comparison fair.[2] Placebo means a look-alike treatment without active medicine.[2]

Intravenous means given into a vein, and oral means taken by mouth.[1][2]

]]> SODIUM IBANDRONATE https://clinicaltrials.eu/drug/sodium-ibandronate/ Wed, 01 Jul 2026 08:57:20 +0000 https://clinicaltrials.eu/drug/sodium-ibandronate/ SODIUM IBANDRONATE Clinical Trials in Osteogenesis Imperfecta

Table of Contents

Trial overview

The source data include one completed interventional study that lists SODIUM IBANDRONATE among its related treatment options.[1] The trial is focused on osteogenesis imperfecta and is designed to study fracture outcomes in this patient group.[1]

Condition and population

The condition studied is osteogenesis imperfecta, which is a disorder linked to fragile bones and a higher risk of fractures.[1] The trial data do not give detailed age limits or other full entry rules, so the exact participant profile cannot be expanded beyond the condition stated in the source.[1]

Study design and phase

This is an interventional study, which means the researchers tested a treatment plan and followed what happened to the participants.[1] It is a Phase 3 trial, so it is in a later testing stage and is meant to assess how well the study approach works in a larger group.[1]

Treatments compared

The brief summary says the study tested a two-year treatment spell with teriparatide, followed by zoledronic acid, and compared this plan with standard care.[1] Standard care could mean no active treatment or treatment with bisphosphonates, depending on patient preference and normal care provider practice.[1] The intervention list also includes SODIUM IBANDRONATE-related products among several bone treatments recorded in the trial data.[1]

Main outcome measured

The main outcome is the proportion of participants who have a clinical fracture confirmed by x-ray or other imaging.[1] This is the primary outcome, meaning it is the most important result the researchers planned to measure.[1] The study is event driven, which means it ends after 139 participants have had a confirmed fracture event, and this was expected after an average of 62 months of follow-up.[1]

Study status and size

The trial is marked as completed in the source data.[1] The enrollment number is 360, which means 360 participants were planned or included in the study record.[1]

]]> Sodium Chloride https://clinicaltrials.eu/drug/sodium-chloride/ Wed, 01 Jul 2026 08:57:19 +0000 https://clinicaltrials.eu/drug/sodium-chloride/ Sodium Chloride in Clinical Trials: Uses, Phases, Outcomes, and Study Populations

Table of Contents

Overview of Sodium Chloride in trials

Sodium Chloride appears in many studies as a placebo, a control, or a comparison fluid.[1] In these trials, the main question is usually about another treatment, procedure, or care strategy, not Sodium Chloride itself.[1]

The trial topics are very broad and include surgery, infection, pain, kidney disease, heart disease, lung disease, brain injury, and allergy testing.[1] Some studies also use Sodium Chloride as part of the study process in early safety research or in procedure-based trials.[1]

What these trials are testing

Many trials compare an active treatment against Sodium Chloride to see if the active treatment improves a health outcome.[1] Examples include pain control after surgery, infection prevention, recovery after critical illness, and changes in organ function.[1]

  • Pain and recovery studies look at things like opioid use, pain scores, mobility, and quality of recovery after surgery.[1]

  • Infection and inflammation studies look at outcomes such as mortality, infection rates, inflammatory markers, and time to clinical recovery.[1]

  • Organ function studies look at kidney, lung, heart, or brain outcomes, such as creatinine, forced vital capacity, ejection fraction, or neurological recovery.[1]

  • Procedure studies compare a treatment or technique with a placebo or sham procedure to see if it improves comfort, safety, or success of the procedure.[1]

Who is included

The target populations are very different from one trial to another.[1] Some studies include adults with chronic diseases such as cirrhosis, cancer, autoimmune disease, chronic pain, or kidney failure.[1]

Other studies focus on special groups such as children, newborns, adolescents, older adults, healthy volunteers, or patients in the intensive care unit (ICU).[1] Some trials also focus on people after surgery, such as cardiac surgery, hip surgery, colon surgery, or brain surgery.[1]

Several studies are aimed at very specific groups, such as people with severe hyponatremia, sickle cell disease, hidradenitis suppurativa, thyroid eye disease, or autism spectrum disorder.[1]

Trial phases and study size

The collection includes a wide mix of trial phases, with many studies in Phase 3 and several in Phase 2.[1] There are also smaller early studies in Phase 1 or Phase 1/2, and some low-intervention studies that mainly compare standard care or fluids.[1]

Enrollment ranges from very small pilot studies with fewer than 20 people to large multicenter trials with thousands of participants.[1] This shows that Sodium Chloride is used across both early research and larger confirmatory studies.[1]

Main outcomes being measured

The primary outcomes depend on the condition being studied and the goal of the trial.[1] Many outcomes are patient-centered, such as pain relief, breathing ability, mobility, recovery scores, or survival.[1]

  • Pain scores are used in many trials, often measured with scales such as the Numeric Rating Scale (NRS) or Visual Analog Scale (VAS).[1]

  • Recovery and function outcomes include walking, mobility scores, quality of recovery questionnaires, and disability scales.[1]

  • Organ injury or function outcomes include kidney injury, lung function, heart function, and brain injury markers.[1]

  • Safety outcomes often include adverse events, serious adverse events, laboratory tests, and vital signs.[1]

Some studies also use imaging tests, blood markers, or disease-specific scales to measure change over time.[1]

Selected important trials

The LOTUS trial studies chronic hemodialysis patients and looks at muscle protein synthesis and hemodynamic effects during a one-week treatment period.[1] Its main outcome is the difference in myofibrillar fractional synthetic rate, which is a measure of muscle protein building.[1]

The LIVER AKI trial compares human albumin with Sodium Chloride 0.9% in patients with decompensated cirrhosis and acute kidney injury, and it measures kidney recovery without the need for renal replacement therapy.[1] This is a Phase 3 study with 114 participants.[1]

The FORE-PAIN trial studies acute traumatic pain in the prehospital setting and compares several pain treatments against controls, including Sodium Chloride used intranasally and intravenously.[1] Its main outcome is the change in pain score 10 minutes after treatment.[1]

The CAT-Trial studies painful diabetic neuropathy and measures average pain intensity over 24 weeks.[1] Sodium Chloride is used as the placebo comparison in this Phase 2 study.[1]

The TICH-3 trial studies tranexamic acid in stroke caused by intracerebral haemorrhage and uses Sodium Chloride Injection as the comparison treatment.[1] The main outcome is early death within 7 days after the bleed.[1]

The LOTUS, LIVER AKI, and TICH-3 studies show how Sodium Chloride is often used to help compare a new treatment against a neutral control in serious hospital conditions.[1]

What this means for patients

If you see Sodium Chloride in a trial record, it often means the study is comparing a new treatment against a standard neutral option.[1] This makes it easier to know whether the active treatment really helps.[1]

These trials do not all study the same illness, so the meaning of participation depends on the condition, age group, and treatment plan in that specific study.[1] Some trials are short and focus on immediate outcomes, while others follow people for months or even years.[1]

]]> Simeticone https://clinicaltrials.eu/drug/simeticone/ Wed, 01 Jul 2026 08:57:17 +0000 https://clinicaltrials.eu/drug/simeticone/ Simeticone Clinical Trials: Bowel Preparation and Endoscopy Studies

Table of contents

Overview of the Simeticone trials

Clinical research on Simeticone in the source data is centered on endoscopy preparation and the quality of bowel cleaning. The studies are not testing Simeticone as a treatment for a disease on its own; instead, they are looking at how it is used in preparation protocols for bowel tests.[1][2]

The main settings are small bowel capsule endoscopy and colorectal cancer screening colonoscopy. These trials aim to see whether the preparation helps doctors view the bowel more clearly and improve key diagnostic results.[1][2]

Small bowel capsule endoscopy study

One authorised interventional study, NCT2025-520671-38-00, evaluates the mucosal visualization quality and diagnostic performance of small bowel capsule endoscopy using different preparation protocols.[1] The brief summary says the goal is to compare the degree of cleaning and the visibility of the small intestine lining in patients having capsule endoscopy.[1]

This study includes 156 participants and is listed as a low intervention trial.[1] The main outcome is the degree of small bowel cleansing, measured with an accepted cleansing scale.[1]

In simple terms, this trial asks whether the preparation method helps the camera capsule take clearer pictures inside the small bowel. Better cleaning can make the test easier to read and may help doctors spot problems more reliably.[1]

Colorectal cancer screening trial

Another authorised study, NCT2025-523748-11-00, is a phase 3 randomized parallel comparative trial in people undergoing colorectal cancer screening colonoscopy.[2] The trial title states that it studies the efficacy and tolerability of a simethicone-containing evacuating solution in this setting.[2]

This study has 818 planned participants and compares two bowel preparation products, Clensia® and Citrafleet®.[2] The main outcome is the adenoma detection rate, which means the proportion of patients in whom at least one adenoma is found during colonoscopy.[2]

This endpoint matters because finding adenomas during screening is a key part of colonoscopy quality. The study is designed to see whether one preparation leads to better detection results in colorectal cancer screening.[2]

Study design, phases, and participants

The Simeticone-related studies in the source data are interventional, which means researchers assign a preparation strategy and then measure results.[1][2] One study is low intervention, while the colorectal screening trial is phase 3.[1][2]

The target populations are people scheduled for endoscopic procedures. One group is patients having small bowel capsule endoscopy, and the other is people undergoing colonoscopy for colorectal cancer screening.[1][2]

The trial data does not describe age limits, sex limits, or other detailed entry rules for these Simeticone studies. Based on the available information, participation depends on being scheduled for the specific endoscopy procedure being studied.[1][2]

Main outcomes measured in the trials

The small bowel capsule endoscopy study measures small bowel cleansing using an accepted scale.[1] This tells researchers how clean the bowel is before or during the test, which affects how well the lining can be seen.[1]

The colorectal screening study measures adenoma detection rate, which is the proportion of patients with at least one adenoma found during the procedure.[2] This is a common way to judge how effective a screening colonoscopy is at finding important bowel growths.[2]

These outcomes are practical and patient-focused. They help show whether a preparation approach improves the quality of the test and supports better diagnosis.[1][2]

What these trials mean for patients

For patients, these studies are about making endoscopy easier to interpret and more useful. In the small bowel study, the focus is on clearer capsule images, while in the colonoscopy study the focus is on finding adenomas during screening.[1][2]

The available trial data suggests that Simeticone is being studied as part of preparation strategies rather than as a stand-alone treatment. The main question is whether it helps improve the quality of bowel cleansing and the results of the endoscopy test.[1][2]

]]> Saline https://clinicaltrials.eu/drug/saline/ Wed, 01 Jul 2026 08:57:15 +0000 https://clinicaltrials.eu/drug/saline/ Saline in Clinical Trials: What the Studies Are Testing

Table of Contents

Trial overview

Across the trials provided, Saline is used mainly as a placebo or comparison treatment, not as the main study drug.[1] The studies are testing many different treatments against Saline in areas such as lung disease, infection, cancer, diabetes, surgery, pain, and immune-related disease.[2] Most of the trials are interventional, which means researchers assign treatments and then measure what happens.[3]

Conditions being studied

The trials cover a wide range of conditions. These include chronic obstructive pulmonary disease (COPD), community-acquired pneumonia, respiratory syncytial virus, obesity, early symptomatic Alzheimer’s disease, pancreatic cancer, advanced chronic ischemia with risk of amputation, ovarian cancer, alpha-1 antitrypsin deficiency-associated liver disease, anal fistula, alcohol use disorder, Dupuytren disease, presymptomatic type 1 diabetes, and postoperative pain or blood loss in surgery.[1][2]

Some studies focus on adults only, such as the RSV vaccine study in immunocompromised patients aged 18 years and older.[3] Other studies include children, such as the trial in pediatric patients with presymptomatic type 1 diabetes and the study of blood loss in pediatric hip surgery.[4][5]

Who can participate

Who can join depends on the disease and the study goal. Some trials recruit people with a specific illness, such as COPD, metastatic pancreatic cancer, or alpha-1 antitrypsin deficiency-associated liver disease.[1][6]

Other studies recruit healthier volunteers or people in a broader group. For example, one trial includes healthy adult participants for propofol injection pain, and another includes healthy volunteers to study liraglutide effects on gut movement and hunger.[7][8]

Some studies also have special target groups, such as immunocompromised patients, older adults aged 80 years and above, or children with diabetes or surgical needs.[3][9][4]

Trial phases and study designs

The data include Phase 1, Phase 2, Phase 3, and one Low Intervention study.[10] Phase 2 trials are common in the list and are used to look more closely at whether a treatment works and to continue safety testing.[10] Phase 3 trials are also common and usually compare treatments in larger groups to confirm benefit and safety.[10]

Several trials are randomized, blinded, or placebo controlled. These designs help reduce bias by making comparisons fairer between the active treatment and Saline.[11]

Main endpoints and outcomes

The primary endpoints vary by study. Some trials measure immune response, such as changes in cytokine production in COPD or interferon-gamma response after vaccination.[1][12]

Other trials measure clinical outcomes that matter to patients, including overall survival in metastatic pancreatic cancer, progression-free survival in ovarian cancer, days alive and out of hospital in pneumonia, pain scores after surgery, blood loss during surgery, and scar quality after wound healing.[6][2][5][13]

Some studies focus on safety and tolerability, such as the trials in early symptomatic Alzheimer’s disease and alpha-1 antitrypsin deficiency-associated liver disease.[14][15] Others measure functional change, such as walking distance, ankle/brachial index, sperm concentration, muscle strength, insulin sensitivity, or time until rescue pain medicine is needed.[16][17][18]

Key studies using Saline

In the COPD vaccine study, Saline is part of a Phase 2 trial that compares vaccination effects on innate immune training, which means the early part of the immune system is being studied for stronger responses after stimulation.[1] In the pneumonia study, Saline is part of a Phase 2 strategy comparing inhaled levofloxacin with standard intravenous antibiotics, and the main result is days alive and out of hospital at 14 days.[2]

In the RSV vaccine study, immunocompromised adults receive Saline or the vaccine, and the main endpoint is the fold increase in RSV-A and RSV-B neutralizing titers, which are antibodies that can block the virus.[3] In the pancreatic cancer trial, Saline is the placebo arm in a large Phase 3 study measuring overall survival.[6]

In the diabetes and immune studies, Saline is used in trials that look at whether treatment can keep children in stage 1 type 1 diabetes and how many adverse events occur over time.[4] In the surgery and pain studies, Saline is used to compare pain relief, blood loss, and nerve block effects after procedures.[5][13][19]

What these trials mean for patients

These studies show that Saline is being used as a comparison treatment across many medical fields.[1] The goal is not to study Saline itself as a treatment, but to see whether the active study drug or procedure works better than Saline.[11]

For patients, this means the trial may be looking at whether a vaccine, medicine, block, infusion, or surgery-related treatment improves outcomes compared with a placebo control.[2][13] The important results vary by condition, but they often include symptoms, recovery, safety, and longer-term health changes.[14][15]

]]> Ruxolitinib https://clinicaltrials.eu/drug/ruxolitinib/ Wed, 01 Jul 2026 08:57:14 +0000 https://clinicaltrials.eu/drug/ruxolitinib/ Ruxolitinib Clinical Trials: Conditions, Phases, and Study Goals

Table of contents

Trial overview

These studies investigate Ruxolitinib in many different diseases, with a strong focus on skin disorders and blood-related conditions.[1] The trial list includes both completed and authorised studies, and the phases range from Phase 1 to Phase 4.[1]

Some trials test Ruxolitinib alone, while others study it with another treatment or against a placebo or vehicle cream.[1] The main goal across the trials is to see whether the treatment is safe and whether it helps patients improve in a measurable way.[1]

Skin condition studies

Several trials focus on skin diseases and use Ruxolitinib cream.[1] In hidradenitis suppurativa, two Phase 3 trials called TRuE-HS1 and TRuE-HS2 are studying whether Ruxolitinib cream can improve disease signs by Week 16, using the HiSCR75 response measure.[1]

In atopic dermatitis, a Phase 3b study in children and adolescents aged 6 to under 18 years is testing Ruxolitinib cream against vehicle cream, with the main outcome being EASI75 at Week 8.[1] A similar Phase 3b study in adults with moderate atopic dermatitis also compares Ruxolitinib cream with vehicle cream and measures EASI75 and IGA-TS at Week 8.[1]

Ruxolitinib cream is also being studied in children aged 6 to under 12 years with non-segmental vitiligo, where the main outcome is F-VASI75 at Week 24.[1] Another Phase 2 study looks at genital vitiligo and measures a genital visibility score at Week 48, asking whether the area becomes less noticeable.[1]

Two Phase 3 studies in prurigo nodularis tested whether Ruxolitinib cream could reduce itching, using the WI-NRS4 response at Week 12.[1] A Phase 2 study in chronic hand eczema also compared Ruxolitinib cream with vehicle cream and measured the IGA-CHE-TS score at Week 16.[1]

Blood and immune system studies

Ruxolitinib is also being studied in myelofibrosis, a bone marrow disease that can cause an enlarged spleen and symptoms such as tiredness.[1] These studies examine Ruxolitinib alone or in combination with other drugs such as selinexor, navtemadlin, axatilimab, navitoclax, KER-050, or roginolisib, depending on the trial.[1]

Common myelofibrosis outcomes include spleen volume reduction, symptom score improvement, and safety measures.[1] For example, several trials measure whether the spleen shrinks by at least 35% after 24 weeks, which is called SVR35.[1] Other studies measure total symptom score, using questionnaires such as MFSAF v4.0a.[1]

Trials in polycythemia vera and essential thrombocythemia compare Ruxolitinib with other standard treatments or best available therapy.[1] One Phase 3 study in high-risk polycythemia vera measures event-free survival, while a Phase 2 study in high-risk polycythemia vera or essential thrombocythemia measures complete clinicohematologic response at month 6.[1]

Ruxolitinib is also being tested in graft-versus-host disease, including newly diagnosed chronic graft-versus-host disease, steroid-refractory chronic graft-versus-host disease, and steroid-refractory acute graft-versus-host disease.[1] These studies measure overall response, usually defined as complete or partial response without needing new systemic therapy.[1]

Other immune-related studies include haemophagocytic lymphohistiocytosis in children and acquired hemophagocytic syndrome in adults in intensive care units.[1] These trials focus on survival, organ failure scores, or survival until stem cell transplant.[1]

Children and young people

Some trials are built specifically for younger patients.[1] These include studies in children with hidradenitis suppurativa, atopic dermatitis, vitiligo, haemophagocytic lymphohistiocytosis, acute lymphoblastic leukemia, and relapsed or refractory leukemia or lymphoma with IL-7R/JAK-STAT pathway changes.[1]

In these studies, the trial teams use child-appropriate outcomes such as skin scores, survival until transplant, minimal residual disease, or best overall response rate.[1] Minimal residual disease means a very small number of cancer cells that may still be present after treatment and can only be found with special tests.[1]

Some pediatric studies also include patients up to age 25 years, especially in transplant and leukemia-related research.[1] This shows that Ruxolitinib research is not limited to adults and is being explored across a wide age range.[1]

Study design and comparators

The trial designs include interventional studies, which means the researchers assign a treatment and then watch what happens.[1] Several studies are randomized and double-blind, meaning patients are assigned by chance and neither the patient nor the study team knows which treatment is being given during the blinded part.[1]

Many skin trials compare Ruxolitinib cream with vehicle cream, which is the same cream base without the active study drug.[1] In blood and immune studies, Ruxolitinib is often compared with corticosteroids, best available therapy, or other active treatments, depending on the condition being studied.[1]

Some studies are combination trials, where Ruxolitinib is used together with another medicine to see whether the pair works better than one treatment alone.[1] Other studies are rollover or extension trials that allow patients to keep receiving treatment while researchers continue to collect safety data over time.[1]

Outcomes measured in the trials

The main outcomes differ by disease, but they all aim to measure a clear treatment result.[1] In skin studies, the outcomes often include improvement in rash, itch, visible lesions, or disease severity scores such as EASI, IGA, WI-NRS, HiSCR75, F-VASI75, and IGA-CHE-TS.[1]

In blood cancer and marrow disease studies, the outcomes often include spleen volume reduction, symptom score changes, complete response, overall response rate, or event-free survival.[1] In transplant and immune studies, outcomes may include survival until HSCT, organ failure scores such as SOFA, relapse rate, graft failure, or time to relapse after transplant.[1]

Safety is also a major endpoint in many trials.[1] Safety outcomes may include adverse events, serious adverse events, vital signs, blood tests, ECG results, and physical examination findings.[1]

Who may join these studies

Eligibility depends on the disease being studied and the exact trial rules.[1] Some trials enroll people who have not yet received treatment, while others look for patients who did not respond to earlier therapy, cannot use standard treatment, or have steroid-refractory disease.[1]

Age limits also vary, with some trials for children only, some for adults only, and some for both children and young adults.[1] Because the studies are focused on specific diseases and treatment histories, not every patient with the same diagnosis can join every trial.[1]

]]> Rosuvastatin Zinc https://clinicaltrials.eu/drug/rosuvastatin-zinc/ Wed, 01 Jul 2026 08:57:13 +0000 https://clinicaltrials.eu/drug/rosuvastatin-zinc/ Rosuvastatin Zinc: A Comprehensive Guide for Patients

Table of Contents

What is Rosuvastatin Zinc?

Rosuvastatin Zinc is a medication that belongs to a class of drugs called statins[1]. It is a cholesterol-lowering medication used to treat various cardiovascular conditions. Rosuvastatin Zinc is the active ingredient in some brand-name medications, and it’s also available as a generic drug.

How Does It Work?

Rosuvastatin Zinc works by inhibiting an enzyme called HMG-CoA reductase, which plays a crucial role in cholesterol production in the liver[1]. By reducing the production of cholesterol, Rosuvastatin Zinc helps to lower the levels of low-density lipoprotein (LDL) cholesterol, often referred to as “bad” cholesterol, in the blood. This action can help reduce the risk of cardiovascular diseases.

Medical Conditions Treated

Rosuvastatin Zinc is primarily used to treat the following conditions:

  • Hypercholesterolemia: A condition characterized by high levels of cholesterol in the blood[1].
  • Primary hypercholesterolaemia: An inherited form of high cholesterol[1].
  • Cardiovascular risk prevention: It is used for both primary and secondary prevention of cardiovascular events in patients with high cardiovascular risk[1].

Dosage and Administration

Rosuvastatin Zinc is typically taken orally in the form of tablets. The dosage can vary depending on the specific condition being treated and the patient’s individual needs. Common dosages range from 5 mg to 40 mg daily[2]. It’s important to take this medication exactly as prescribed by your healthcare provider.

Potential Side Effects

Like all medications, Rosuvastatin Zinc can cause side effects. Some of the potential side effects include:

  • Musculoskeletal adverse reactions: These can include muscle pain or weakness[1].
  • Headache
  • Nausea
  • Abdominal pain
  • Constipation

It’s important to note that not everyone experiences these side effects, and many people take Rosuvastatin Zinc without any significant problems. However, if you experience any unusual symptoms while taking this medication, you should contact your healthcare provider.

Ongoing Research

Rosuvastatin Zinc is the subject of ongoing research to better understand its effects and potential uses. Some current areas of study include:

  • The relationship between genetic factors and the effectiveness of Rosuvastatin Zinc in reducing musculoskeletal adverse reactions[1].
  • The effects of Rosuvastatin Zinc on kidney function in patients with impaired renal function and suspected metabolic dysfunction-associated steatotic liver disease (MASH)[2].
  • The potential impact of Rosuvastatin Zinc on steroid hormones, bile acids, muscle morphology, vitamin D, and the immune system[3].

Important Considerations

When taking Rosuvastatin Zinc, it’s important to keep the following in mind:

  • Always take the medication as prescribed by your healthcare provider.
  • Inform your doctor about any other medications you’re taking, as some drugs can interact with Rosuvastatin Zinc.
  • Regular blood tests may be necessary to monitor your cholesterol levels and liver function while taking this medication.
  • Maintain a healthy lifestyle, including a balanced diet and regular exercise, to support the effectiveness of the medication.
  • If you experience any unusual symptoms or side effects, contact your healthcare provider promptly.

Remember, Rosuvastatin Zinc is a powerful medication that can significantly improve your cardiovascular health when used correctly. Always consult with your healthcare provider for personalized advice and guidance on using this medication.

]]> Ropivacaine Hydrochloride https://clinicaltrials.eu/drug/ropivacaine-hydrochloride/ Wed, 01 Jul 2026 08:57:13 +0000 https://clinicaltrials.eu/drug/ropivacaine-hydrochloride/ Ropivacaine Hydrochloride Clinical Trials: What They Study and Who They Include

Table of contents

Clinical trial overview

These studies look at Ropivacaine Hydrochloride in many different clinical settings, mainly for pain control around surgery and other procedures.[1] The trials aim to measure whether it improves pain relief, recovery, mobility, or the need for extra pain medicine.[1]

Most of the listed trials are Phase 3 studies, which means they are later-stage studies that test treatments in larger groups of patients.[1] A smaller number are low-intervention studies or a Phase 2 study.[1]

Conditions and procedures being studied

The trials cover a wide range of conditions, including acute low back pain, hip osteoarthrosis, breast cancer surgery, lumbar arthrodesis, tonsillectomy, urolithiasis, total hip arthroplasty, knee osteoarthritis, and chronic neuropathic pain after mastectomy.[1]

Several studies focus on specific operations, such as cesarean section, cardiac surgery, hernia repair, shoulder surgery, hand surgery, colon surgery, renal surgery, and periacetabular osteotomy.[1] Others study pain after procedures like closed reduction of wrist fractures or treatment of hemorrhoidal disease.[1]

Some trials also include people with cancer-related conditions, such as advanced epithelial ovarian cancer, renal cancer, breast cancer, colorectal cancer surgery, and severe refractory cancer pain.[1]

Who may take part

Participants vary by study, because each trial is designed for a specific group of patients.[1] Some trials include people having planned surgery, while others include emergency patients, pregnant women in labor, or people with ongoing pain conditions.[1]

Examples of target groups include patients with acute low back pain, patients undergoing total hip or knee replacement, women having mastectomy, and people needing regional pain blocks for orthopedic or abdominal surgery.[1] One study also focuses on healthy volunteers to compare nerve block methods.[1]

Some trials are very specific about who can join. For example, one study includes pregnant women who request epidural analgesia for labor, while another includes patients needing subpectoral implantation of cardiac implantable electronic devices.[1]

Main outcomes and endpoints

The main outcomes often measure how much pain a patient has after the procedure, using tools such as the Visual Analog Scale (VAS) or the Numeric Rating Scale (NRS).[1] These are simple pain scores where a higher number usually means more pain.[1]

Several trials also measure the time until the first request for rescue analgesia, which means extra pain medicine given when the main treatment is not enough.[1] Other endpoints include return of sensory and motor function, postoperative recovery scores, mobility, bleeding during surgery, and quality of life.[1]

Examples of study-specific outcomes include pain reduction 30 minutes after a block, pain during the first 72 hours after tonsillectomy, pain at 24 hours after surgery, and the time from surgery or anesthesia to the first need for extra pain medicine.[1]

Trial phases and study designs

Most studies are interventional studies, meaning the research team gives a treatment or procedure and then measures the result.[1] Many are randomized or double-blind, which helps reduce bias by making comparisons fairer.[1]

The most common phase is Phase 3, with studies comparing Ropivacaine Hydrochloride against placebo, saline, or another pain method such as bupivacaine, lidocaine, clonidine, dexmedetomidine, or magnesium sulfate.[1] There is also a Phase 2 study in healthy volunteers looking at nerve block effects.[1]

Some studies are marked as completed, some as authorised, and a few were withdrawn before completion.[1]

What Ropivacaine Hydrochloride is compared with

In many trials, Ropivacaine Hydrochloride is tested against placebo, which is an inactive comparison treatment such as saline.[1] This helps show whether the pain relief comes from the study treatment itself.[1]

Other trials compare it with different local anesthetics or with a nerve block technique that uses another medicine mix.[1] Examples include comparisons with bupivacaine, lidocaine, levobupivacaine, and combinations with adjuvants such as magnesium sulfate, dexmedetomidine, or clonidine.[1]

Some studies do not compare the drug alone, but instead test whether adding Ropivacaine Hydrochloride to a block or infiltration method improves recovery, comfort, or pain scores after surgery.[1]

Selected trial examples

  • Acute low back pain: One Phase 3 study tests an erector spinae plane block to reduce pain and help patients move sooner after treatment, with outcomes measured 30 minutes after the procedure.[1]

  • Total hip arthroplasty: Several Phase 3 studies look at postoperative pain, return of sensory and motor function, walking ability, and the need for rescue pain medicine after hip replacement surgery.[1]

  • Breast surgery: Some trials study pain control after mastectomy or other breast cancer surgery using nerve blocks that include Ropivacaine Hydrochloride.[1]

  • Labor analgesia: One Phase 3 study includes pregnant women requesting epidural pain relief during labor and measures whether the sensory block is complete enough after 45 minutes.[1]

  • Abdominal and colorectal surgery: Trials in hernia repair, colon surgery, and colorectal cancer surgery measure postoperative recovery, pain scores, and morphine use.[1]

]]> Risedronate Sodium https://clinicaltrials.eu/drug/risedronate-sodium/ Wed, 01 Jul 2026 08:57:12 +0000 https://clinicaltrials.eu/drug/risedronate-sodium/ Risedronate Sodium: A Comprehensive Guide for Patients

Table of Contents

What is Risedronate Sodium?

Risedronate Sodium is a medication that belongs to a class of drugs called bisphosphonates. It is commonly known by its brand names Actonel and Benet[1]. This medication is primarily used to treat and prevent certain bone conditions, particularly those related to reduced bone density[2].

What Conditions Does Risedronate Sodium Treat?

Risedronate Sodium is used to treat several conditions related to bone health:

  • Postmenopausal Osteoporosis: This is a condition where bones become weak and brittle after menopause, increasing the risk of fractures[3].
  • Osseous Paget’s Disease: A chronic disorder that can result in enlarged and misshapen bones[1].
  • Glucocorticoid-Induced Osteoporosis (GIO): This is bone loss caused by long-term use of steroid medications[4].
  • Prevention of Bone Loss in Cancer Patients: Specifically in patients receiving high-dose corticosteroids for the treatment of acute lymphocytic leukemia (ALL) and lymphoblastic lymphoma (LL)[5].

How Does Risedronate Sodium Work?

Risedronate Sodium works by slowing down bone loss in your body. It helps to maintain or increase bone density and reduces the risk of fractures. The medication does this by:

  • Inhibiting bone breakdown (resorption)
  • Promoting bone formation
  • Improving bone mineral density (BMD)

These effects are measured through various bone turnover markers, which are substances in the blood or urine that indicate the rate of bone formation and breakdown[6].

Dosage Forms and Administration

Risedronate Sodium comes in different dosage forms and strengths:

  • 5 mg tablets taken daily[3]
  • 35 mg tablets taken once a week[7]
  • 75 mg tablets taken once a month[8]
  • 150 mg tablets taken once a month[2]

The medication should be taken with a full glass of water (about 180 mL) on an empty stomach, at least 30 minutes before the first food, drink, or other medication of the day. Patients should remain upright (sitting or standing) for at least 30 minutes after taking the medication to reduce the risk of esophageal irritation[8].

Effectiveness of Risedronate Sodium

Clinical trials have shown that Risedronate Sodium is effective in:

  • Increasing bone mineral density (BMD) in various parts of the body, including the lumbar spine, femur neck, and total hip[6]
  • Reducing the risk of new vertebral and non-vertebral fractures[6]
  • Improving bone turnover markers, indicating a positive effect on bone metabolism[8]

Potential Side Effects and Safety

While Risedronate Sodium is generally well-tolerated, it can cause some side effects. Common side effects may include:

  • Gastrointestinal issues (such as stomach pain, nausea, or diarrhea)
  • Muscle and joint pain
  • Headache

Rare but serious side effects can include osteonecrosis of the jaw (a severe bone disease affecting the jaw) and atypical femur fractures. It’s important to discuss any concerns or unusual symptoms with your healthcare provider[1].

Patient Satisfaction and Compliance

Studies have been conducted to assess patient satisfaction and compliance with different dosing regimens of Risedronate Sodium. Some patients may prefer the once-weekly or once-monthly dosing options over daily dosing, as it may be more convenient and improve adherence to the medication regimen[7].

Monitoring During Treatment

During treatment with Risedronate Sodium, your healthcare provider may monitor several aspects of your health:

  • Bone Mineral Density (BMD): Usually measured by dual-energy X-ray absorptiometry (DXA) scans
  • Bone Turnover Markers: Blood and urine tests to measure substances that indicate bone formation and breakdown
  • Height Measurements: To monitor for potential height loss due to vertebral fractures
  • Calcium and Vitamin D Levels: As these nutrients are crucial for bone health

Regular follow-ups and these monitoring tests help ensure the medication is working effectively and safely[6][8].

]]> Pravastatin Sodium https://clinicaltrials.eu/drug/pravastatin-sodium/ Wed, 01 Jul 2026 08:57:03 +0000 https://clinicaltrials.eu/drug/pravastatin-sodium/ Pravastatin Sodium: A Comprehensive Guide for Patients

Table of Contents

What is Pravastatin Sodium?

Pravastatin Sodium is a medication that belongs to a class of drugs called statins. It’s also known by the brand name Pravachol[1]. Statins are primarily used to lower cholesterol levels in the blood, but they have other beneficial effects as well[2].

What Conditions Does Pravastatin Treat?

Pravastatin is used to treat several conditions related to heart health and cholesterol levels:

  • Primary Hyperlipidemia: This is a condition where there are high levels of fats (lipids) in the blood, particularly cholesterol[3].
  • Mixed Dyslipidemia: This refers to abnormal levels of multiple types of lipids in the blood[3].
  • Acute Coronary Syndromes: These are a range of conditions related to sudden, reduced blood flow to the heart[4].

Interestingly, pravastatin is also being studied for potential use in other conditions:

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD): A genetic disorder that causes cysts to grow in the kidneys[2].
  • Preeclampsia: A pregnancy complication characterized by high blood pressure and signs of damage to other organ systems[5].
  • Endometriosis: A painful disorder in which tissue similar to the tissue that normally lines the inside of the uterus grows outside the uterus[6].

How Does Pravastatin Work?

Pravastatin works by blocking an enzyme in the liver that is responsible for producing cholesterol. By doing this, it helps to lower the levels of LDL cholesterol (often called “bad” cholesterol) in the blood[3].

Beyond its cholesterol-lowering effects, pravastatin has other beneficial properties:

  • It may help protect blood vessels and reduce inflammation[2].
  • In pregnancy-related studies, it’s being investigated for its potential to prevent preeclampsia by affecting certain proteins involved in the condition[5].
  • For endometriosis, researchers are exploring its anti-inflammatory properties as a potential treatment option[6].

Dosage and Administration

Pravastatin is typically taken orally (by mouth) in tablet form. The dosage can vary depending on the condition being treated and the individual patient. Some common dosages seen in clinical trials include:

  • 40 mg once daily[2]
  • 80 mg once daily[7]

It’s important to note that the appropriate dosage should always be determined by a healthcare provider. Never adjust your dosage without consulting your doctor first.

Clinical Studies and Effectiveness

Pravastatin has been the subject of numerous clinical studies to evaluate its effectiveness in various conditions:

  • In studies comparing pravastatin to other statins like atorvastatin, it has shown effectiveness in reducing the risk of death or major cardiovascular events in patients with acute coronary syndromes[4].
  • A study comparing pravastatin 40 mg to pitavastatin 4 mg in patients with primary hyperlipidemia or mixed dyslipidemia looked at the mean percent change in LDL cholesterol levels over 12 weeks[3].
  • Ongoing research is investigating pravastatin’s potential in preventing preeclampsia in high-risk pregnant women[5].

Potential Side Effects

Like all medications, pravastatin can cause side effects. Common side effects may include:

  • Muscle pain or weakness
  • Headache
  • Nausea
  • Diarrhea

More serious side effects, though rare, can include liver problems and a condition called rhabdomyolysis, which involves the breakdown of muscle tissue. It’s important to report any unusual symptoms to your healthcare provider[2].

Special Considerations

There are some special considerations to keep in mind when taking pravastatin:

  • Pregnancy: While statins are generally not recommended during pregnancy, pravastatin is being studied for potential use in preventing preeclampsia in high-risk pregnancies[5].
  • Liver function: Your doctor may monitor your liver function while you’re taking pravastatin[2].
  • Drug interactions: Pravastatin can interact with other medications. Always inform your healthcare provider about all medications you’re taking[2].

Remember, while this information provides a general overview of pravastatin, it’s crucial to consult with your healthcare provider for personalized advice and treatment recommendations.

]]> Potassium Chloride https://clinicaltrials.eu/drug/potassium-chloride/ Wed, 01 Jul 2026 08:57:02 +0000 https://clinicaltrials.eu/drug/potassium-chloride/ Potassium Chloride: A Comprehensive Guide for Patients

Table of Contents

What is Potassium Chloride?

Potassium chloride is a medication used to treat and prevent low potassium levels in the blood, a condition known as hypokalemia. It is an essential mineral that plays a crucial role in various bodily functions, including heart rhythm, muscle contractions, and nerve signaling[1].

Potassium chloride is also known by its chemical formula KCl and is classified as an electrolyte supplement[1]. It’s important to note that potassium levels in the body need to be carefully balanced, as both low and high levels can cause serious health problems.

Medical Uses of Potassium Chloride

Potassium chloride is primarily used to treat and prevent hypokalemia. This condition can occur due to various reasons, including:

  • Certain medications (e.g., diuretics)
  • Excessive sweating or fluid loss
  • Kidney problems
  • Certain heart conditions

In addition to treating hypokalemia, potassium chloride is used in specific medical scenarios:

  1. Cardiac Surgery: It’s often used in pediatric cardiac intensive care units to manage potassium levels after heart surgery[2].
  2. Contrast-Induced Nephropathy Prevention: Some research is exploring its use in preventing kidney damage caused by contrast agents used in certain medical imaging procedures[3].
  3. Brain-Dead Organ Donors: It’s being studied for use in maintaining organ function in brain-dead organ donors[4].

How is Potassium Chloride Administered?

Potassium chloride can be administered in several ways, depending on the patient’s condition and the healthcare setting:

  1. Oral Supplements: These are often used for mild cases of hypokalemia or for maintenance therapy. They come in various forms such as tablets, capsules, or liquid[2].
  2. Intravenous (IV) Infusion: This method is commonly used in hospital settings, especially for patients who cannot take oral medications or who need rapid correction of potassium levels. It can be given as:
    • Continuous infusion: A steady, slow infusion over time
    • Intermittent infusion: Larger doses given at intervals

    The choice between these methods often depends on the severity of hypokalemia and the patient’s overall condition[1].

The dosage and administration method are carefully determined by healthcare providers based on the patient’s potassium levels, kidney function, and other factors.

Safety and Side Effects

While potassium chloride is an essential medication, it requires careful monitoring due to potential risks:

  • Hyperkalemia: Excessive potassium levels can be dangerous and potentially lead to heart rhythm problems[1].
  • Gastrointestinal Issues: Oral potassium supplements can cause stomach upset, nausea, vomiting, or diarrhea[2].
  • Cardiac Arrhythmias: Rapid changes in potassium levels can affect heart rhythm[1].

Due to these potential risks, potassium chloride is often considered a “high-alert medication,” especially when given intravenously. This means that extra precautions are taken to ensure its safe use[2].

Current Research and Clinical Trials

Several ongoing clinical trials are exploring new uses and administration methods for potassium chloride:

  1. Contrast-Induced Nephropathy Prevention: A study is investigating whether potassium nitrate (a related compound) can help prevent kidney damage caused by contrast agents used in coronary angiography procedures[3].
  2. Brain-Dead Organ Donors: Researchers are studying the use of potassium canrenoate (another potassium-based medication) in maintaining organ function in brain-dead organ donors[4].
  3. Comparison of Administration Methods: Studies are comparing the effectiveness and safety of different potassium chloride administration methods, such as continuous IV infusion versus intermittent infusion, and oral versus IV administration[1][2].

These studies aim to improve our understanding of how to use potassium chloride most effectively and safely in various medical situations.

]]> Pitavastatin Calcium https://clinicaltrials.eu/drug/pitavastatin-calcium/ Wed, 01 Jul 2026 08:56:58 +0000 https://clinicaltrials.eu/drug/pitavastatin-calcium/ Pitavastatin Calcium: A Comprehensive Guide for Patients

Table of Contents

What is Pitavastatin Calcium?

Pitavastatin Calcium, also known by the brand name LIVALO[1] or Alipza[2], is a medication that belongs to a class of drugs called statins. Statins are commonly used to lower cholesterol levels in the blood. Pitavastatin works by reducing the amount of cholesterol produced by the liver, which helps to manage various conditions related to high cholesterol and blood fats (lipids).

Uses of Pitavastatin Calcium

Pitavastatin Calcium is primarily used to treat the following conditions:

  • Hyperlipidemia: This is a condition characterized by high levels of fats (lipids) in the blood, including cholesterol and triglycerides[1].
  • Dyslipidemia: A disorder of lipoprotein metabolism, including lipoprotein overproduction or deficiency[3].
  • Prediabetes: A condition where blood sugar levels are higher than normal but not high enough to be diagnosed as diabetes[3].
  • Hypertension: High blood pressure, often associated with cardiovascular risks[3].

Dosage and Administration

Pitavastatin Calcium is typically taken orally in tablet form. The dosage can vary depending on the specific condition being treated and the individual patient’s needs. Some common dosages include:

  • 2 mg once daily[1]
  • 4 mg once daily[1]

In some clinical trials, higher doses of up to 48 mg daily have been studied for specific purposes[2]. However, it’s important to note that the dosage should always be determined by a healthcare professional based on individual patient factors and treatment goals.

Effects on Blood Sugar Levels

One of the key areas of research for Pitavastatin Calcium is its effect on blood sugar levels, particularly in patients with prediabetes or at risk of developing diabetes. Studies have been conducted to evaluate:

  • Changes in HbA1c levels (a measure of long-term blood sugar control)[3]
  • Changes in fasting plasma glucose (FPG) levels[3]
  • Changes in oral glucose tolerance test (OGTT) results[3]

These studies aim to determine if Pitavastatin has a more favorable effect on glucose metabolism compared to other statins, potentially making it a preferred choice for patients with or at risk of diabetes[3].

Other Potential Benefits

Research suggests that Pitavastatin Calcium may have additional benefits beyond cholesterol reduction:

  • Improvement in inflammatory markers, such as C-reactive protein (CRP)[3]
  • Potential reduction in cardiovascular disease (CVD) events[3]
  • Possible improvements in vascular endothelial function and arterial stiffness[3]
  • Potential effects on heart structure, as measured by left ventricular mass index (LVMI)[3]
  • Possible reduction in carotid intima-media thickness (CIMT), a marker of atherosclerosis[3]

Side Effects and Safety

As with all medications, Pitavastatin Calcium can cause side effects. Common side effects may include muscle pain, headache, and digestive issues. However, the specific side effect profile is being studied in ongoing clinical trials[3].

It’s important for patients to report any unusual symptoms or side effects to their healthcare provider. Regular monitoring of liver function and muscle enzymes may be recommended while taking this medication.

Ongoing Research

Pitavastatin Calcium is the subject of ongoing research to explore its potential in various medical conditions:

  • Glioblastoma: A phase 0 trial is investigating whether Pitavastatin can reach effective concentrations in brain tumor tissue, potentially opening new avenues for cancer treatment[2].
  • Prediabetes and Hypertension: Studies are comparing Pitavastatin to other statins like Atorvastatin to assess its effects on glucose metabolism and cardiovascular risk factors in patients with prediabetes and high blood pressure[3].

These ongoing studies aim to provide more information about the potential uses and benefits of Pitavastatin Calcium in various patient populations.

]]> Pamidronate Disodium https://clinicaltrials.eu/drug/pamidronate-disodium/ Wed, 01 Jul 2026 08:56:54 +0000 https://clinicaltrials.eu/drug/pamidronate-disodium/ Pamidronate Disodium: A Comprehensive Guide for Patients

Table of Contents

What is Pamidronate Disodium?

Pamidronate Disodium is a medication that belongs to a class of drugs called bisphosphonates. It is also known by several other names, including Aminomux, APD, Aredia, and GCP-23339A[1]. This drug is primarily used to treat conditions affecting bone health and to manage certain types of cancer that impact the bones.

Conditions Treated with Pamidronate

Pamidronate is used to treat various conditions related to bone health and certain cancers. Some of the main conditions it’s used for include:

  • Multiple Myeloma: A type of blood cancer that affects plasma cells in the bone marrow[2]
  • Bone Metastases: When cancer spreads to the bones, particularly in breast cancer patients[3]
  • Avascular Necrosis of the Femoral Head: A condition where bone tissue dies due to lack of blood supply[4]
  • SAPHO Syndrome: A rare condition affecting the skin, bones, and joints[5]
  • Bone Loss after Organ Transplantation: Particularly after liver and kidney transplants[6][7]
  • Chronic Low Back Pain: In some cases, pamidronate is being studied for its potential in managing chronic low back pain[8]

How Pamidronate Works

Pamidronate works in several ways to help improve bone health and manage certain conditions:

  • Slowing Bone Breakdown: It helps to slow down the process of bone breakdown (resorption) in the body[6]
  • Increasing Bone Density: By reducing bone breakdown, it can help increase overall bone density[9]
  • Reducing Pain: In conditions like bone metastases, it can help reduce bone pain[3]
  • Preventing Skeletal-Related Events: In cancer patients, it can help prevent complications like fractures or spinal cord compression[3]

How Pamidronate is Administered

Pamidronate is typically administered intravenously (through a vein). The dosage and frequency can vary depending on the condition being treated:

  • For multiple myeloma or bone metastases, it’s often given every 3-4 weeks[3]
  • For other conditions, it may be given less frequently, such as every few months[4]
  • The infusion usually takes about 2-4 hours[2]

Current Research Areas

Researchers are currently exploring new uses for pamidronate and ways to optimize its use:

  • Chronic Low Back Pain: Studies are investigating if pamidronate can help manage chronic low back pain[8]
  • Combination Therapies: Research is being done on combining pamidronate with other drugs like arsenic trioxide for treating certain cancers[1]
  • Optimizing Treatment Schedules: Studies are looking at different dosing schedules to find the most effective way to administer the drug[3]
  • Local Application: Some research is exploring the local application of pamidronate during hip replacement surgery to prevent bone loss around the implant[9]

Potential Side Effects

Like all medications, pamidronate can cause side effects. Some potential side effects include:

  • Flu-like symptoms (fever, chills, body aches)
  • Nausea or vomiting
  • Fatigue
  • Low blood calcium levels
  • Kidney problems (in rare cases)
  • Osteonecrosis of the jaw (a rare but serious condition affecting the jawbone)

It’s important to discuss potential side effects with your healthcare provider before starting treatment with pamidronate[6].

]]> Mexiletine https://clinicaltrials.eu/drug/mexiletine/ Wed, 01 Jul 2026 08:56:39 +0000 https://clinicaltrials.eu/drug/mexiletine/ Mexiletine: A Medication for Muscle Stiffness and Heart Rhythm Problems

Table of Contents

What is Mexiletine?

Mexiletine is a medication that belongs to a class of drugs called antiarrhythmics. It is also known by the brand names Namuscla and Mexitil[1]. Mexiletine was originally developed to treat irregular heart rhythms, but researchers have found that it can also help with certain muscle disorders[2].

What Conditions Does Mexiletine Treat?

Mexiletine is used to treat several conditions affecting muscles and heart rhythm:

  • Non-dystrophic myotonias (NDM): These are rare genetic disorders that cause muscle stiffness and difficulty relaxing muscles after use. Two types of NDM treated with mexiletine are:
    • Myotonia congenita
    • Paramyotonia congenita[3]
  • Myotonic dystrophy: A genetic disorder causing muscle weakness and difficulty relaxing muscles[2]
  • Cardiac arrhythmias: Irregular heart rhythms[4]

Researchers are also studying mexiletine for other conditions, such as:

  • Amyotrophic lateral sclerosis (ALS): A progressive nervous system disease affecting nerve cells in the brain and spinal cord[4]
  • Irritable bowel syndrome with constipation (IBS-C): A disorder affecting the large intestine[5]
  • Focal dystonia: A neurological disorder causing involuntary muscle contractions[6]

How Does Mexiletine Work?

Mexiletine works by affecting the way sodium moves in and out of muscle and nerve cells. This action helps to stabilize cell membranes and reduce abnormal electrical activity. In muscle disorders, this can help muscles relax more easily after contracting. In heart rhythm disorders, it can help regulate the heartbeat[1].

How is Mexiletine Taken?

Mexiletine is usually taken by mouth in the form of capsules. The dosage and frequency can vary depending on the condition being treated and the patient’s response. In clinical trials, some common dosing regimens include:

  • 200 mg three times daily[1]
  • 150 mg three times daily[2]
  • Gradual increase from 200 mg once daily to 200 mg three times daily over the course of a week[3]

It’s important to follow your doctor’s instructions carefully when taking mexiletine.

How Effective is Mexiletine?

Clinical trials have shown that mexiletine can be effective in treating muscle stiffness (myotonia) in patients with non-dystrophic myotonias and myotonic dystrophy. Some of the improvements observed include:

  • Reduced muscle stiffness[2]
  • Faster muscle relaxation after contraction[3]
  • Improved ability to perform daily activities[2]
  • Better quality of life[2]

However, the effectiveness can vary from person to person, and not all patients may experience the same level of improvement.

What are the Potential Side Effects?

Like all medications, mexiletine can cause side effects. Some potential side effects observed in clinical trials include:

  • Gastrointestinal issues (nausea, indigestion)[2]
  • Dizziness[4]
  • Headache[4]
  • Changes in heart rhythm (monitored by ECG)[2]

It’s important to discuss potential side effects with your doctor and report any unusual symptoms while taking mexiletine.

Ongoing Research on Mexiletine

Researchers continue to study mexiletine to better understand its effects and potential uses. Some areas of ongoing research include:

  • Long-term safety and effectiveness in children and adolescents with myotonic disorders[7]
  • Use in treating muscle cramps and twitches in ALS patients[4]
  • Effects on colon function in patients with certain genetic mutations[5]
  • Comparison of different doses to find the most effective and safe treatment regimens[8]

These ongoing studies may provide more information about mexiletine’s benefits and risks in the future.

]]> Mexiletine Hydrochloride https://clinicaltrials.eu/drug/mexiletine-hydrochloride/ Wed, 01 Jul 2026 08:56:39 +0000 https://clinicaltrials.eu/drug/mexiletine-hydrochloride/ Mexiletine Hydrochloride: A Potential Treatment for Painful Neuropathy in HIV Patients

Table of Contents

What is Mexiletine Hydrochloride?

Mexiletine Hydrochloride is a medication that has shown promise in managing painful neuropathies, particularly in patients with HIV infections[1]. Neuropathy is a condition that affects the nerves, often causing pain, numbness, or weakness in various parts of the body. In the context of HIV infections, neuropathy can be a challenging and painful complication for many patients.

Medical Conditions Treated

According to the clinical trial data, Mexiletine Hydrochloride is being studied for its effectiveness in treating:

  • HIV-related painful peripheral neuropathy: This is a type of nerve damage that occurs in some people with HIV, causing pain, burning sensations, or numbness, typically in the hands and feet[1].
  • Peripheral Nervous System Disease: This broader category includes various conditions affecting the nerves outside the brain and spinal cord[1].

Clinical Trial Overview

A Phase II/III double-blind study was conducted to assess the efficacy, safety, and tolerability of Mexiletine Hydrochloride in reducing pain intensity for patients with HIV-related painful peripheral neuropathy[1]. This trial is significant because it represents one of the first large-scale controlled clinical trials for symptomatic therapy of painful HIV-related neuropathy.

Comparison with Other Medications

In the clinical trial, Mexiletine Hydrochloride was compared with two other medications:

  1. Amitriptyline Hydrochloride: Another medication used for managing painful neuropathies[1].
  2. Benztropine Mesylate: Used as an active placebo in the study to mimic the side effects of the other drugs[1].

The inclusion of Benztropine Mesylate as an active placebo is an interesting aspect of this study. An active placebo is a substance that produces similar side effects to the drugs being tested but doesn’t have the same therapeutic effect. This helps to maintain the “blind” nature of the study, as participants are less likely to guess which treatment they’re receiving based on side effects.

Dosage and Administration

The clinical trial provides some insights into how Mexiletine Hydrochloride might be administered:

  • Doses were gradually increased over 4 weeks until a minimum effective dose or maximum tolerated dose (MTD) was reached[1].
  • After reaching the effective or maximum dose, patients were treated for at least 4 additional weeks[1].
  • If no pain relief was observed after 14 days, the dose could be doubled or increased to the maximum allowable dose[1].
  • If no improvement occurred within 14 days after the dose increase, patients had the option to discontinue the medication[1].

Potential Side Effects

While the clinical trial data doesn’t provide specific information about side effects of Mexiletine Hydrochloride, it’s mentioned that both Mexiletine and Amitriptyline are associated with certain toxicities[1]. The use of Benztropine Mesylate as an active placebo to mimic mild side effects suggests that patients might experience some mild adverse effects while taking Mexiletine Hydrochloride. However, it’s important to note that the specific nature and severity of these side effects are not detailed in the provided information.

]]> Methylprednisolone Acetate https://clinicaltrials.eu/drug/methylprednisolone-acetate/ Wed, 01 Jul 2026 08:56:38 +0000 https://clinicaltrials.eu/drug/methylprednisolone-acetate/ Methylprednisolone Acetate: A Comprehensive Guide for Patients

Table of Contents

What is Methylprednisolone Acetate?

Methylprednisolone Acetate is a type of steroid medication that belongs to the class of drugs known as corticosteroids. It is also known by brand names such as Depo-Medrol[1]. This medication is a synthetic (man-made) version of hormones naturally produced by the adrenal glands. It works by reducing inflammation and suppressing the immune system, which can be beneficial in treating various medical conditions[2].

Medical Uses

Methylprednisolone Acetate is used to treat a variety of conditions characterized by inflammation or overactive immune responses. Some of the conditions it’s commonly used for include:

  • Carpal Tunnel Syndrome: A condition causing numbness and tingling in the hand and arm[3]
  • Gout: A type of arthritis characterized by sudden, severe attacks of pain, swelling, redness and tenderness in joints[1]
  • Lumbar Spine Disc Herniation and Radiculitis: Conditions affecting the lower back and causing pain that may radiate to the legs[2]
  • Post-operative Inflammation: Inflammation following surgical procedures, such as cataract surgery[4]

How is it Administered?

Methylprednisolone Acetate is typically administered as an injection. The method of injection can vary depending on the condition being treated:

  • Intramuscular (IM) Injection: The medication is injected directly into a muscle. For example, in the treatment of gout, a dose of 120mg may be given as an IM injection[1].
  • Intracarpal Injection: For conditions like carpal tunnel syndrome, the medication may be injected directly into the affected area of the wrist[3].
  • Epidural Injection: In cases of back pain or disc herniation, the medication may be injected into the space around the spinal cord[2].

Effectiveness

Methylprednisolone Acetate has been shown to be effective in reducing inflammation and pain in various conditions. For instance:

  • In lumbar spine conditions, it has been found to provide pain relief lasting from one week up to one year[2].
  • For post-operative inflammation in cataract surgery, it has been shown to effectively control inflammation[4].

Potential Side Effects

While Methylprednisolone Acetate can be effective, it’s important to be aware of potential side effects. These may include:

  • Worsening of diabetes
  • Increased blood pressure
  • Effects on heart disease

These side effects are particularly important to consider in patients with kidney disease or other underlying health conditions[1].

Comparisons with Other Medications

Methylprednisolone Acetate is often compared to other medications in clinical trials:

  • Vs. Dexamethasone: Both are used in epidural injections for back pain, but their effectiveness may differ[2].
  • Vs. Ozone Therapy: In treating carpal tunnel syndrome, methylprednisolone acetate is being compared to ozone injections[3].
  • Vs. Anakinra: For gout treatment, especially in patients with kidney disease, methylprednisolone is being compared to anakinra, a newer medication that targets a specific inflammatory pathway[1].

Use in Special Populations

Methylprednisolone Acetate requires special consideration in certain patient groups:

  • Patients with Kidney Disease: The use of this medication in patients with chronic kidney disease is being studied, as these patients may be more susceptible to side effects[1].
  • Diabetic Patients: Care should be taken when using this medication in diabetic patients, as it can affect blood sugar levels[5].
]]> Macrogol 4000 https://clinicaltrials.eu/drug/macrogol-4000/ Wed, 01 Jul 2026 08:56:34 +0000 https://clinicaltrials.eu/drug/macrogol-4000/ Macrogol 4000 Clinical Trials

Table of Contents

Overview of the trials

The trial data show that Macrogol 4000 is being studied in patient groups where bowel cleansing or bowel function is important.[1][2] The main research areas are elective colonoscopy, constipation prevention after hip surgery, and colorectal cancer screening colonoscopy.[1][2][3]

Most of the listed studies are Phase 3 trials, while some are Phase 2 trials in other clinical settings.[1][2][3][4][5] This means the research is focused on comparing treatments in larger groups and checking outcomes that matter to patients and doctors.[1][2]

Bowel preparation for colonoscopy

One completed Phase 3 study, CLEARWAY, looked at adults scheduled for elective colonoscopy performed according to ESGE guidelines.[1] It compared mannitol with Plenvu®, which contains MACROGOL, COMBINATIONS in the intervention list, and studied whether the bowel was cleaned well enough for the procedure.[1]

The primary endpoint was the proportion of patients with adequate bowel cleansing, defined by the BBPS total score and segment scores in the right, transverse, and left colon.[1] In simple terms, the study checked how clean each part of the bowel was so the endoscopist could see clearly during colonoscopy.[1]

Another Phase 3 study, CLEAN+, focused on colorectal cancer early detection colonoscopy.[3] It compared two bowel preparation products, Clensia® and Citrafleet®, and measured the adenoma detection rate, which is the share of patients in whom at least one adenoma was found.[3]

Although CLEAN+ does not list Macrogol 4000 by name in the intervention field, it belongs to the same broad area of bowel preparation research and shows how these trials focus on the quality of colonoscopy screening.[3]

Constipation prevention after hip surgery

The trial titled “What laxatives after hip surgery?” is a Phase 3 study in patients with hip fracture.[2] It compares MACROGOL, COMBINATIONS with bisacodyl to find the best way to prevent constipation after surgery.[2]

The main endpoint is the proportion of patients who need rescue medication after 72 hours or before 72 hours based on medical assessment.[2] This endpoint shows whether the first laxative plan was enough or whether extra treatment was needed.[2]

This study is important because it looks at a common problem after hip surgery: constipation, which can cause discomfort and slow recovery.[2] The trial is designed to compare treatment options in a real patient group after surgery.[2]

Other studies in the trial data

The trial data also include a Phase 2 study in intensive care patients who were intoxicated by toxic substances and were intubated.[4] That study used digestive decontamination treatments and measured the change in plasma toxic substance levels at 24 hours.[4]

Another Phase 2 study, RESCUE-HUB, involved patients with unresectable hepatocellular carcinoma and tested fecal microbiota transplantation added to atezolizumab plus bevacizumab after early progression.[5] Its endpoints included safety, measured by severe adverse events, and efficacy, measured by disease control rate at 12 weeks.[5]

These studies are part of the same source set, but they do not directly study Macrogol 4000 as the main intervention in the way the colonoscopy and hip surgery trials do.[4][5]

Main endpoints and how results are measured

Across the trial data, the main endpoints are practical measures that show whether the treatment worked.[1][2][3] For colonoscopy studies, the focus is on bowel cleanliness and adenoma detection.[1][3]

For the hip surgery study, the key measure is whether patients needed rescue medication after the planned laxative treatment.[2] In the cancer and intensive care studies, the endpoints are disease control, safety, or changes in toxic substance levels.[4][5]

These endpoints are useful because they show not just whether a treatment was given, but whether it helped in a clear and measurable way.[1][2]

Study design, phases, and who can join

The listed studies are interventional, which means researchers assign treatments and then compare outcomes between groups.[1][2][3][4][5] The colonoscopy study CLEARWAY is randomized, parallel-group, and endoscopist-blinded, which helps make the comparison fair and reduces bias.[1]

The target populations are clearly defined in each trial: adults scheduled for elective colonoscopy, patients with hip fracture after surgery, intensive care patients with toxic ingestion, and patients with unresectable hepatocellular carcinoma.[1][2][4][5] Enrollment ranges from small studies with 15 participants to larger studies with more than 800 participants.[1][3][5]

Overall, the trial data show that Macrogol 4000 is being explored mostly in settings where bowel preparation or bowel regularity matters, with outcomes chosen to reflect real clinical needs.[1][2]

]]> Lidocaine Hydrochloride Monohydrate https://clinicaltrials.eu/drug/lidocaine-hydrochloride-monohydrate/ Wed, 01 Jul 2026 08:56:29 +0000 https://clinicaltrials.eu/drug/lidocaine-hydrochloride-monohydrate/ Lidocaine Hydrochloride Monohydrate: A Comprehensive Guide for Patients

Table of Contents

What is Lidocaine Hydrochloride Monohydrate?

Lidocaine Hydrochloride Monohydrate is a medication that belongs to a class of drugs called local anesthetics[1]. It works by blocking nerve signals in your body, which helps to reduce pain and discomfort in specific areas. This drug is commonly known by its shorter name, lidocaine. It’s important to note that lidocaine is different from general anesthetics, which make you unconscious during surgery. Instead, lidocaine keeps you awake but numbs a particular part of your body.

Medical Uses

Lidocaine has several important medical uses:

  • Local anesthesia: It’s used to numb specific areas of the body during minor surgical procedures, dental work, or when inserting medical devices[2].
  • Pain relief: Lidocaine can help manage various types of pain, including post-surgical pain and certain chronic pain conditions.
  • Cardiac arrhythmias: In some cases, lidocaine is used to treat irregular heartbeats[2].
  • Gastrointestinal issues: Research is being conducted on the use of oral lidocaine to prevent gastrointestinal disturbances in patients after abdominal surgery[3].

How is it Administered?

Lidocaine can be administered in several ways, depending on its intended use:

  • Injection: For local anesthesia, lidocaine is often injected directly into the area that needs to be numbed[4].
  • Topical application: It can be applied to the skin as a cream, ointment, or patch for localized pain relief.
  • Intravenous (IV) use: In some medical settings, lidocaine may be given through an IV for certain heart conditions or as part of a pain management strategy[5].
  • Oral form: Some research is exploring the use of oral lidocaine for specific conditions, such as preventing gastrointestinal issues after surgery[3].

Dosage Information

The dosage of lidocaine varies widely depending on its use, the specific formulation, and individual patient factors. For example:

  • For local anesthesia, the dose can range from 1 to 5 mg/kg of body weight[5].
  • In research on oral lidocaine for gastrointestinal issues, doses up to 400 mg per day are being studied[3].

It’s crucial to emphasize that lidocaine should only be administered by or under the supervision of a healthcare professional. They will determine the appropriate dose based on your specific situation, medical history, and other factors.

Potential Side Effects

Like all medications, lidocaine can cause side effects. Most side effects are mild and temporary, but some can be serious. Common side effects may include:

  • Numbness or tingling at the application site
  • Mild dizziness or lightheadedness
  • Nausea
  • Vomiting

More serious side effects, which require immediate medical attention, can include:

  • Allergic reactions (rash, itching, swelling)
  • Severe dizziness or fainting
  • Irregular heartbeat
  • Seizures
  • Difficulty breathing

It’s important to report any unusual symptoms to your healthcare provider promptly[6].

Precautions and Contraindications

Certain conditions or factors may affect the use of lidocaine:

  • Allergies: If you’re allergic to lidocaine or similar local anesthetics, you should not use this medication.
  • Liver or kidney disease: These conditions may affect how your body processes lidocaine.
  • Heart conditions: Lidocaine can affect heart rhythm, so it should be used with caution in people with certain heart problems.
  • Pregnancy and breastfeeding: The safety of lidocaine during pregnancy and breastfeeding should be discussed with a healthcare provider.

Always inform your healthcare provider about all medications you’re taking, including over-the-counter drugs and supplements, as they may interact with lidocaine[6].

Ongoing Research

Lidocaine is being studied for various potential uses beyond its current applications. Some areas of ongoing research include:

  • Gastrointestinal issues: A study is investigating the use of oral lidocaine to prevent gastrointestinal disturbances in patients after abdominal surgery[3].
  • Pain management: Researchers are exploring new ways to use lidocaine for managing different types of pain, including chronic pain conditions.
  • Combination therapies: Studies are looking at how lidocaine might work in combination with other medications to enhance pain relief or reduce side effects.

These research efforts aim to expand our understanding of lidocaine’s potential benefits and optimize its use in medical care. However, it’s important to remember that research findings may not immediately translate into new approved uses, and any new applications would need to go through rigorous testing and regulatory approval processes before becoming widely available.

]]> Lamivudine https://clinicaltrials.eu/drug/lamivudine/ Wed, 01 Jul 2026 08:56:25 +0000 https://clinicaltrials.eu/drug/lamivudine/ Lamivudine: A Comprehensive Guide for Patients

Table of Contents

What is Lamivudine?

Lamivudine, also known by its brand names Epivir, Zeffix, or Combivir (when combined with other medications), is an antiviral medication used to treat various viral infections[1][2][3]. It belongs to a class of drugs called nucleoside reverse transcriptase inhibitors (NRTIs), which work by interfering with the replication of viruses in the body[1].

Uses of Lamivudine

Lamivudine is primarily used to treat two main conditions:

  1. HIV Infection: Lamivudine is an essential component of many antiretroviral therapy (ART) regimens used to treat Human Immunodeficiency Virus (HIV) infection[4][5]. It is often combined with other antiretroviral drugs to create effective treatment plans for people living with HIV.
  2. Chronic Hepatitis B: Lamivudine is also used to treat chronic hepatitis B virus (HBV) infection in adults[6][2]. It can help reduce the amount of hepatitis B virus in the body and improve liver function.

How Lamivudine Works

Lamivudine works by interfering with the replication process of viruses like HIV and HBV. Here’s a simplified explanation of how it functions:

  • When viruses like HIV or HBV infect cells, they use an enzyme called reverse transcriptase to replicate their genetic material.
  • Lamivudine mimics one of the building blocks (nucleosides) that the virus needs to create new copies of itself.
  • When the virus tries to use lamivudine instead of the real nucleoside, it disrupts the replication process, preventing the virus from making new copies efficiently[1].

By reducing viral replication, lamivudine helps lower the amount of virus in the body, which can slow down the progression of the disease and improve the patient’s overall health.

Dosage and Administration

Lamivudine is typically taken orally in tablet form. The dosage can vary depending on the condition being treated and other factors. Here are some common dosing regimens:

  • For HIV treatment: 300 mg once daily or 150 mg twice daily, often as part of a combination therapy[1].
  • For chronic hepatitis B: 100 mg once daily[2].

It’s important to note that dosages may be adjusted based on individual patient factors, such as kidney function or age. Always follow your healthcare provider’s instructions regarding dosage and administration.

Effectiveness

Lamivudine has shown effectiveness in treating both HIV and chronic hepatitis B:

  • In HIV treatment, lamivudine is often used as part of combination antiretroviral therapy. It helps suppress viral replication, leading to reduced HIV RNA levels in the blood (viral load) and improved CD4+ T cell counts, which are important markers of immune system health[4][5].
  • For chronic hepatitis B, lamivudine can help normalize liver enzyme levels, reduce HBV DNA levels, and in some cases, lead to HBeAg seroconversion (a sign of improved immune control over the virus)[6].

However, it’s important to note that the effectiveness of lamivudine can be limited by the development of drug resistance, especially when used as monotherapy (single-drug treatment) for extended periods[7].

Side Effects and Safety

Like all medications, lamivudine can cause side effects. Common side effects may include:

  • Headache
  • Nausea
  • Fatigue
  • Diarrhea
  • Abdominal pain

More serious side effects, though less common, can include:

  • Lactic acidosis (a buildup of lactic acid in the body)
  • Liver problems
  • Changes in body fat distribution

It’s important to discuss any side effects with your healthcare provider. Regular monitoring of liver function, kidney function, and blood tests may be necessary while taking lamivudine[1].

Ongoing Research

Research on lamivudine continues to explore its potential uses and optimize its effectiveness:

  • Studies are investigating the use of lamivudine in combination with other antiretroviral drugs to improve treatment outcomes and reduce side effects in HIV patients[5].
  • Research is ongoing to determine the optimal duration of lamivudine therapy for chronic hepatitis B patients and to develop strategies to prevent or manage drug resistance[2].
  • Interestingly, some research is exploring the potential use of lamivudine in treating certain types of cancer, such as p53 mutant metastatic colorectal cancer[3]. However, this is still in the experimental stage and not an approved use of the drug.

As research progresses, our understanding of lamivudine’s benefits and optimal use continues to evolve. Always consult with your healthcare provider for the most up-to-date information about your treatment options.

]]> Iloprost Trometamol https://clinicaltrials.eu/drug/iloprost-trometamol/ Wed, 01 Jul 2026 08:56:16 +0000 https://clinicaltrials.eu/drug/iloprost-trometamol/ ILOPROST TROMETAMOL: A Comprehensive Guide for Patients

Table of Contents

What is Iloprost Trometamol?

Iloprost Trometamol, also known simply as Iloprost, is a medication that belongs to a class of drugs called prostacyclin analogs. It is a synthetic compound that mimics the effects of a natural substance in your body called prostacyclin[1]. Prostacyclin helps to widen blood vessels and prevent blood clots. Iloprost is primarily used to treat various conditions related to blood circulation and has been the subject of recent clinical trials exploring its potential in other medical applications.

Medical Conditions Treated

Traditionally, Iloprost has been used to treat several medical conditions, including:

  • Pulmonary arterial hypertension: A condition where the blood pressure in the arteries of the lungs is too high
  • Raynaud’s phenomenon: A condition that affects blood flow to certain parts of the body, usually the fingers and toes
  • Scleroderma: A group of rare diseases that involve the hardening and tightening of the skin and connective tissues

Recent clinical trials are exploring the use of Iloprost in new areas, such as bone healing and respiratory conditions[1][2].

How is Iloprost Administered?

Iloprost is typically administered as an infusion, which means it’s given directly into the bloodstream through a vein. The medication comes in the form of a concentrate that is diluted and then given as a solution for infusion[1][2]. The exact dosage and duration of treatment can vary depending on the condition being treated and the individual patient’s needs.

Iloprost for Bone Healing

A recent clinical trial is investigating the use of Iloprost in improving bone healing for patients with upper arm (proximal humeral) fractures[1]. This study, known as the ILOBONE trial, is exploring a new application of Iloprost:

  • The medication is being applied locally at the fracture site during surgery
  • Researchers are studying if this method can promote better bone healing
  • The trial includes patients aged 40 to 80 years old who are undergoing surgery for specific types of upper arm fractures

This research could potentially open up new treatment options for patients with difficult-to-heal bone fractures.

Iloprost in Respiratory Conditions

Another ongoing clinical trial, called COMBAT-ARF, is investigating the use of Iloprost in patients with severe respiratory conditions[2]. This study is focusing on:

  • Patients with infectious pulmonary endotheliopathy, a condition where the infection affects the lining of blood vessels in the lungs
  • Adult patients who require mechanical ventilation (breathing support from a machine)
  • The potential of Iloprost to reduce mortality (death rates) in these severely ill patients

This research aims to determine if Iloprost can improve outcomes for patients with severe lung infections who require intensive care.

Safety Considerations

As with any medication, Iloprost has potential side effects and safety considerations. Some important points to note include:

  • Iloprost may not be suitable for patients with certain heart conditions, including severe coronary heart disease, unstable angina, or recent heart attacks[1]
  • It should be used cautiously in patients with a history of bleeding disorders or recent strokes[1][2]
  • Pregnant or breastfeeding women should consult their doctor before using Iloprost[1]
  • Some patients may have allergies to Iloprost or its ingredients[2]

Always consult with your healthcare provider about potential risks and benefits before starting any new medication.

Ongoing Research

The clinical trials mentioned in this article are part of ongoing research to expand our understanding of Iloprost’s potential uses. These studies are investigating:

  • The safety and effectiveness of Iloprost in new applications, such as bone healing and severe respiratory conditions[1][2]
  • Different methods of administering the drug, including local application at fracture sites[1]
  • The impact of Iloprost on patient outcomes, including mortality rates and recovery times[2]

As research continues, we may discover new ways that Iloprost can benefit patients with various medical conditions. It’s important to note that while these studies are promising, their results are not yet conclusive, and more research may be needed before any new uses for Iloprost are approved.

]]> IBANDRONIC ACID https://clinicaltrials.eu/drug/ibandronic-acid/ Wed, 01 Jul 2026 08:56:14 +0000 https://clinicaltrials.eu/drug/ibandronic-acid/ IBANDRONIC ACID Clinical Trials in Bone Fragility Research

Table of contents

Trial overview

The trial record linked to IBANDRONIC ACID is a completed interventional study, which means researchers gave study treatments and then measured what happened.[1] The study ID is 2024-519705-36-00 and it was run as a Phase 3 trial with 360 planned participants.[1]

Although the trial title lists several bone medicines, the record shows that IBANDRONIC ACID was one of the study drugs included in the intervention list.[1]

Condition studied

The trial studied osteogenesis imperfecta, a condition that makes bones fragile and easier to break.[1] This is why the main focus of the study was fracture prevention and bone health.[1]

Study design and phase

This was a Phase 3 study, which is a later stage of clinical research used to test how well a treatment works in a larger group of people.[1] The study was event-driven, meaning it was planned to continue until a set number of fracture events had occurred.[1]

The primary outcome was expected to be reached after an average follow-up of 62 months, based on the number of fractures observed.[1]

Who participated

The trial planned to include 360 participants.[1] The source data do not give a more detailed age range or other eligibility rules, so the safest description is that the study involved people with osteogenesis imperfecta who were suitable for this Phase 3 bone study.[1]

What the study measured

The main endpoint was the proportion of participants experiencing a clinical fracture that was confirmed by x-ray or other imaging.[1] An endpoint is the main result a trial measures to see whether the treatment works.[1]

This endpoint is important because fractures are the key problem in osteogenesis imperfecta, and confirmed imaging helps make sure the outcome is counted correctly.[1]

Treatment comparison and standard care

The brief summary says the study compared a treatment plan of teriparatide followed by zoledronic acid with standard care.[1] Standard care in this trial could mean no active treatment or treatment with bisphosphonates, depending on patient and provider preference.[1]

The intervention list also included several bone medicines, including IBANDRONIC ACID, but the source does not explain the exact role of each listed medicine in the final comparison.[1]

What these trial results mean for patients

For patients, the most important point is that this research was designed to see whether a treatment strategy could lower the chance of broken bones in people with osteogenesis imperfecta.[1] Because the trial is completed, the study question has already been tested, but the source data provided here do not include the final results.[1]

The trial does not provide enough detail to say that IBANDRONIC ACID alone was the only study treatment, so it should be understood as one of the listed medicines in a broader bone research setting.[1]

]]> Fluvastatin Sodium https://clinicaltrials.eu/drug/fluvastatin-sodium/ Wed, 01 Jul 2026 08:55:59 +0000 https://clinicaltrials.eu/drug/fluvastatin-sodium/ Fluvastatin Sodium: A Comprehensive Guide for Patients

Table of Contents

What is Fluvastatin?

Fluvastatin sodium, also known by brand names such as Lescol or Lescol XL, is a medication that belongs to a class of drugs called statins[1]. Statins are widely used to treat high cholesterol levels and reduce the risk of cardiovascular diseases. Fluvastatin works by lowering the amount of cholesterol produced by the body, particularly the “bad” cholesterol known as low-density lipoprotein (LDL) cholesterol[2].

Uses of Fluvastatin

Fluvastatin is primarily used to treat the following conditions:

  • Hypercholesterolemia: This is a condition characterized by high levels of cholesterol in the blood. Fluvastatin helps lower cholesterol levels, especially LDL cholesterol[1].
  • Mixed Dyslipidemia: This condition involves abnormal levels of multiple types of fats (lipids) in the blood, including cholesterol and triglycerides[2].
  • Cardiovascular Risk Reduction: Fluvastatin is used in patients with high cardiovascular risk, such as those with coronary heart disease or diabetes, to reduce the risk of heart attacks and strokes[1].
  • Metabolic Syndrome: This is a cluster of conditions that increase the risk of heart disease, stroke, and diabetes. Fluvastatin has been studied for its effects on patients with metabolic syndrome[3].

How Fluvastatin Works

Fluvastatin works by inhibiting an enzyme called HMG-CoA reductase, which is responsible for producing cholesterol in the liver. By reducing cholesterol production, fluvastatin helps lower the levels of LDL cholesterol and total cholesterol in the blood. This can help prevent the buildup of plaque in the arteries, reducing the risk of heart disease and stroke[1].

In addition to its cholesterol-lowering effects, fluvastatin may have other beneficial effects on the body, known as “pleiotropic effects.” These include improving the function of the blood vessel lining (endothelium) and reducing inflammation[4].

Dosage Forms

Fluvastatin is available in different dosage forms:

  • Immediate Release Capsules: Usually taken twice daily[2].
  • Extended Release Tablets: Taken once daily, typically at bedtime. These are often referred to as Fluvastatin XL or Lescol XL[3].

The dosage can range from 20 mg to 80 mg per day, depending on the patient’s condition and response to treatment[1][3].

Effectiveness

Clinical studies have shown that fluvastatin is effective in:

  • Reducing LDL cholesterol levels by a significant percentage[2].
  • Improving overall lipid profiles, including total cholesterol, HDL cholesterol, and triglycerides[3].
  • Potentially reducing inflammation markers in the body, which may contribute to its cardiovascular benefits[5].

Potential Side Effects

While fluvastatin is generally well-tolerated, it can cause side effects in some patients. Common side effects may include:

  • Muscle pain or weakness
  • Elevated liver enzymes
  • Digestive issues such as nausea or constipation

In rare cases, more serious side effects such as severe muscle damage (rhabdomyolysis) or liver problems may occur. It’s important to discuss any side effects with your healthcare provider[1].

Use in Special Populations

Fluvastatin has been studied in various patient populations, including:

  • Transplant Recipients: Studies have investigated the use of fluvastatin in heart and kidney transplant patients to manage cholesterol levels and potentially reduce cardiovascular risks[6][7].
  • Patients with Antiphospholipid Syndrome: Research has explored the potential of fluvastatin to reduce inflammation and blood clot risk in these patients[5].
  • Patients with Aortic Stenosis: Studies have investigated whether fluvastatin can slow the progression of this heart valve condition[8].

Ongoing Research

Researchers continue to study fluvastatin for potential new uses and to better understand its effects on the body. Some areas of ongoing research include:

  • Effects on brown adipose tissue (brown fat) and its potential impact on insulin resistance[9].
  • Potential benefits in improving erectile function in men with cardiovascular risk factors[4].
  • Use in combination with other cholesterol-lowering drugs like ezetimibe for enhanced effectiveness[1].

It’s important to note that fluvastatin should only be taken under the guidance of a healthcare professional. They will consider your individual health status, risk factors, and potential drug interactions when prescribing this medication.

]]> DROSPIRENONE https://clinicaltrials.eu/drug/drospirenone/ Wed, 01 Jul 2026 08:55:47 +0000 https://clinicaltrials.eu/drug/drospirenone/ Drospirenone: A Comprehensive Guide for Patients

Table of Contents

What is Drospirenone?

Drospirenone is a synthetic progestin (a type of hormone similar to the naturally occurring hormone progesterone) used in various contraceptive formulations and hormonal treatments. What makes drospirenone unique among progestins is that it has properties similar to natural progesterone and is also a potent inhibitor of mineralocorticoid activity (meaning it can affect how your body manages salt and water) [1]. This gives drospirenone some distinct advantages in treating certain conditions.

Drospirenone is commonly found in birth control pills, but it’s also being studied and used as a standalone medication. It has several medical applications beyond contraception, including treatment of endometriosis, polycystic ovary syndrome (PCOS), acne, and premenstrual symptoms.

Medical Uses

Clinical trials have shown that drospirenone can be effective for several medical conditions:

  • Contraception (birth control)
  • Treatment of endometriosis and adenomyosis
  • Management of PCOS (Polycystic Ovary Syndrome)
  • Treatment of acne
  • Relief of premenstrual symptoms
  • Hormone replacement therapy (when combined with estradiol)

Drospirenone for Contraception

Drospirenone is widely used in oral contraceptives, both in combination with estrogens and as a progestin-only pill. Several clinical trials have demonstrated its effectiveness as a contraceptive [2].

Drospirenone-only pills typically contain 4 mg of drospirenone and are taken once daily. These are sometimes called “mini-pills” and are an option for women who cannot or choose not to take estrogen-containing contraceptives [3]. Research indicates that drospirenone effectively inhibits ovulation when taken daily, making it an effective birth control method.

Combined oral contraceptives containing drospirenone typically include drospirenone (3 mg) along with ethinyl estradiol (0.02-0.03 mg) or estetrol (15 mg). These are usually taken in a 24/4 regimen (24 days of active hormone tablets followed by 4 days of inactive tablets or low-dose tablets) [4].

Drospirenone-containing contraceptives work by:

  • Inhibiting ovulation (preventing the release of an egg from the ovary)
  • Thickening cervical mucus to prevent sperm from reaching the egg
  • Thinning the uterine lining, making it less receptive to implantation

Studies are also investigating the potential use of drospirenone for emergency contraception. One clinical trial is exploring whether a single high dose of drospirenone could effectively prevent pregnancy after unprotected intercourse [5]. This could potentially provide an additional option for emergency contraception, particularly for women with higher BMI for whom current options may be less effective.

Drospirenone for Endometriosis and Adenomyosis

Endometriosis is a chronic condition where tissue similar to the uterine lining grows outside the uterus, causing pain and potentially infertility. Adenomyosis is a related condition where the endometrial tissue grows into the muscle wall of the uterus.

Clinical trials have shown that drospirenone may be effective in treating these conditions [6]. One study is investigating the use of drospirenone (4 mg daily) for 20 weeks to treat adenomyosis, with the primary goal of reducing chronic pain associated with the condition [7].

When combined with estetrol (a naturally occurring estrogen), drospirenone has been shown to reduce the size of ovarian endometriomas (also called “chocolate cysts”) [8]. This combination is being studied for its ability to:

  • Reduce the size of endometriomas
  • Relieve pain associated with endometriosis
  • Prevent recurrence of endometriosis after surgery
  • Lower levels of CA125 (a blood marker often elevated in endometriosis)

For women with endometriosis-associated pelvic pain, drospirenone has shown promise in clinical trials. It works by reducing the proliferation of endometrial tissue and decreasing the expression of Ki-67 (a marker of cell proliferation) in the endometrium [9].

Drospirenone for PCOS

Polycystic Ovary Syndrome (PCOS) is a common hormonal disorder affecting women of reproductive age. It’s characterized by irregular periods, excess androgen levels (male hormones), and polycystic ovaries. PCOS often presents with symptoms like hirsutism (excess hair growth), acne, and sometimes obesity and insulin resistance.

Drospirenone, particularly when combined with ethinyl estradiol, has been used to treat PCOS [10]. This combination works by:

  • Reducing androgen levels, which helps with symptoms like excess hair growth and acne
  • Regulating menstrual cycles
  • Protecting the uterine lining from abnormal growth

One notable property of drospirenone is its anti-androgenic effect, which means it counteracts male hormones in the body. This makes it particularly useful for PCOS patients who often have elevated androgen levels [11].

A clinical trial is currently exploring whether drospirenone can be used to prevent LH (luteinizing hormone) surge in PCOS cases undergoing assisted reproductive technology (ART) cycles [12]. LH surge in PCOS can lead to premature ovulation or ovarian hyperstimulation syndrome during fertility treatments, so controlling it could improve outcomes.

Drospirenone for Acne

Acne is a common skin condition that can be influenced by hormonal factors. Due to its anti-androgenic properties, drospirenone-containing contraceptives have been shown to be effective in treating moderate acne [13].

A large clinical trial evaluated the efficacy of YAZ (drospirenone 3 mg / ethinyl estradiol 20 μg) for treating moderate acne over 6 treatment cycles. The study found that this formulation significantly reduced total acne lesion count compared to placebo [14].

Drospirenone helps with acne by:

  • Reducing the production of sebum (skin oil) by blocking androgen effects on sebaceous glands
  • Decreasing inflammation associated with acne
  • Regulating hormonal fluctuations that can trigger acne breakouts

Drospirenone for Premenstrual Syndrome

Premenstrual syndrome (PMS) and its more severe form, premenstrual dysphoric disorder (PMDD), can cause significant physical and emotional symptoms before menstruation. Drospirenone has unique properties that make it effective for managing these symptoms [15].

Unlike other progestins, drospirenone has antimineralocorticoid activity, which means it helps the body eliminate excess water. This can reduce bloating and fluid retention commonly experienced during PMS. Its antiandrogenic properties may also help with premenstrual acne flare-ups.

A clinical trial investigated the use of drospirenone/ethinyl estradiol for premenstrual worsening of depression, showing that it can help stabilize mood fluctuations associated with the menstrual cycle [16].

Cardiovascular Effects

Drospirenone’s impact on the cardiovascular system is being studied in clinical trials. One study is evaluating the effect of different hormonal contraceptives, including drospirenone-only pills and combinations with estrogens, on 24-hour blood pressure in cycling women [17].

The antimineralocorticoid activity of drospirenone may offer advantages for certain women, particularly those with tendency toward fluid retention or slightly elevated blood pressure. However, it’s important to note that like other hormonal contraceptives, drospirenone-containing products may increase the risk of blood clots in some women, particularly those with other risk factors [18].

Another study examined the effects of combined estradiol and drospirenone treatment versus combined estradiol and medroxyprogesterone acetate treatment on endothelial function (the function of the cells lining blood vessels) [19]. This research helps to understand how different hormone combinations might affect cardiovascular health.

Effects on Bone Health

The impact of hormonal contraceptives on bone health is an important consideration, particularly for younger women who are still developing bone mass and for long-term users. Clinical trials are investigating the effects of drospirenone on bone mineral density (BMD) [20].

One ongoing study is comparing the effects of drospirenone-containing contraceptives with non-hormonal contraceptive methods on BMD in both adolescent and adult women [21]. This research will help determine whether drospirenone has any significant impact on bone development or maintenance.

For adolescents in particular, understanding the effects of hormonal contraceptives on bone health is crucial, as these are years when peak bone mass is being established.

Different Formulations

Drospirenone is available in several different formulations:

  • Drospirenone-only pills: Typically containing 4 mg of drospirenone, taken daily [22]
  • Combined with ethinyl estradiol: Common formulations include 3 mg drospirenone with either 0.02 mg or 0.03 mg ethinyl estradiol [23]
  • Combined with estetrol: A newer formulation containing 3 mg drospirenone with 15 mg estetrol [24]
  • Combined with estradiol: Used primarily for hormone replacement therapy in menopausal women [25]
  • Chewable tablets: A newer formulation of drospirenone that can be chewed rather than swallowed whole [26]

The choice of formulation depends on the specific medical needs of the patient, potential side effects, and personal preferences. For example, women who cannot take estrogen might opt for a drospirenone-only pill, while those with PCOS might benefit from a combined formulation with ethinyl estradiol.

Side Effects and Safety

Like all medications, drospirenone can cause side effects. Common side effects may include:

  • Headache
  • Nausea
  • Breast tenderness
  • Mood changes
  • Irregular bleeding or spotting, especially during the first few months
  • Changes in weight

Due to its antimineralocorticoid properties, drospirenone can increase potassium levels in some people. This is generally not a problem for healthy individuals, but may be a concern for those with kidney, liver, or adrenal disease, or for those taking medications that can also increase potassium levels [27].

As with other hormonal contraceptives, there is a slightly increased risk of blood clots, particularly in women with other risk factors such as smoking, obesity, or a personal or family history of clotting disorders. However, the overall risk is still low for most women [28].

Clinical trials continue to monitor the safety of drospirenone in various populations and formulations, with many studies including specific safety outcomes to better understand its risk profile [29].

Special Considerations

Certain groups of patients may need special consideration when using drospirenone:

Women with obesity: Studies are investigating the pharmacokinetics (how the drug moves through the body) of drospirenone in obese women, including before and after bariatric surgery [30]. This research will help determine whether dosage adjustments might be needed for women with higher body weight.

Adolescents: The effect of drospirenone on bone mineral density in adolescents is being studied, as this is an important period for bone development [31].

Women with kidney or liver problems: Due to drospirenone’s effect on potassium levels, women with impaired kidney or liver function may need careful monitoring when using this medication [32].

Women taking other medications: Drospirenone can interact with certain medications, particularly those that also affect potassium levels. Always inform your healthcare provider about all medications you’re taking [33].

In conclusion, drospirenone is a versatile hormone medication used in various formulations for contraception and to treat several conditions including PCOS, endometriosis, acne, and premenstrual symptoms. Its unique properties make it particularly useful for certain groups of women, though like all medications, it comes with potential side effects and considerations. Always discuss with your healthcare provider to determine if a drospirenone-containing product is right for you.

]]> Dolutegravir Sodium https://clinicaltrials.eu/drug/dolutegravir-sodium/ Wed, 01 Jul 2026 08:55:46 +0000 https://clinicaltrials.eu/drug/dolutegravir-sodium/ Dolutegravir Sodium: A Comprehensive Guide for Patients

Table of Contents

What is Dolutegravir?

Dolutegravir sodium, also known by its brand names Tivicay[1] or Dotilavir[2], is a powerful medication used in the treatment of Human Immunodeficiency Virus (HIV) infection. It belongs to a class of drugs called integrase strand transfer inhibitors (INSTIs), which are considered some of the most effective medications for managing HIV.

Uses of Dolutegravir

Dolutegravir is primarily used to treat HIV-1 infection in adults and children. It can be used in various scenarios:

  • As part of initial treatment for people newly diagnosed with HIV[3]
  • To replace other HIV medications in people who have already achieved viral suppression (when the amount of HIV in the blood is very low)[4]
  • In combination with other antiretroviral drugs to maintain viral suppression[5]
  • For patients who have developed resistance to other HIV medications[6]

How Dolutegravir Works

Dolutegravir works by blocking an enzyme called integrase that HIV needs to multiply. By doing this, it helps prevent the virus from making copies of itself and infecting more cells in your body. This action helps to reduce the amount of HIV in your blood (known as viral load) and increase your CD4 cell count (a type of white blood cell that fights infection)[7].

Dosage and Administration

Dolutegravir is typically taken as a tablet once or twice daily, depending on your specific situation. The usual dose for adults is 50 mg once daily, but this can vary based on factors such as:

  • Whether you’re taking it for the first time or switching from another medication
  • If you’re also taking certain other medications
  • If you have resistance to other HIV medications

In some cases, such as when taken with certain tuberculosis medications, the dose may need to be increased to 50 mg twice daily[8]. Always follow your healthcare provider’s instructions regarding dosage.

Effectiveness of Dolutegravir

Clinical trials have shown that dolutegravir is highly effective in treating HIV. It has demonstrated good virological and immunological outcomes in both new patients and those who have been treated before[9]. In many cases, it has been shown to be non-inferior or even superior to other HIV medications in maintaining viral suppression[10].

Potential Side Effects

Like all medications, dolutegravir can cause side effects, although not everyone experiences them. Common side effects may include:

  • Headache
  • Nausea
  • Diarrhea
  • Sleep problems

More serious side effects are rare but can occur. These may include allergic reactions or liver problems. Always inform your healthcare provider of any side effects you experience[11].

Special Considerations

There are some special considerations when taking dolutegravir:

  • Drug interactions: Dolutegravir can interact with other medications, including some for tuberculosis. Your doctor will need to know all medications you’re taking[12].
  • Pregnancy: If you’re pregnant or planning to become pregnant, discuss this with your doctor. There have been concerns about potential birth defects when dolutegravir is taken early in pregnancy, although recent data suggest this risk may be lower than initially thought[13].
  • Liver disease: If you have liver problems, your doctor may need to monitor you more closely while taking dolutegravir.

Ongoing Research

Researchers continue to study dolutegravir to understand its long-term effects and explore new ways it can be used. Some ongoing areas of research include:

  • Using dolutegravir in two-drug regimens instead of the traditional three-drug combinations for HIV treatment[14]
  • Investigating its effectiveness in children and adolescents[15]
  • Studying its use in patients who also have tuberculosis[16]
  • Exploring its potential to reduce HIV-related immune activation[17]

These ongoing studies aim to further improve HIV treatment and potentially simplify medication regimens for people living with HIV.

]]> Denosumab https://clinicaltrials.eu/drug/denosumab/ Wed, 01 Jul 2026 08:55:42 +0000 https://clinicaltrials.eu/drug/denosumab/ DENOSUMAB: A Comprehensive Guide for Patients

Table of Contents

What is Denosumab?

Denosumab is a medication used to treat various bone-related conditions. It is known by several brand names, including Xgeva[1], Prolia[2], and AMG 162[3]. Denosumab is a type of drug called a monoclonal antibody, which means it’s a laboratory-produced molecule that acts like the antibodies naturally produced by our immune system.

What Conditions Does Denosumab Treat?

Denosumab is used to treat several conditions related to bone health and certain types of cancer:

  • Osteoporosis: A condition where bones become weak and brittle, increasing the risk of fractures[3]
  • Multiple Myeloma: A type of blood cancer that affects plasma cells and can lead to bone damage[4]
  • Bone Metastases: When cancer spreads from its original site to the bones[5]
  • Giant Cell Tumor of Bone (GCTB): A rare, usually non-cancerous tumor that develops in bones[1]
  • Osteogenesis Imperfecta: A genetic disorder characterized by fragile bones that break easily[6]

How Does Denosumab Work?

Denosumab works by targeting a protein called RANKL (Receptor Activator of Nuclear Factor Kappa-B Ligand). This protein plays a crucial role in the formation and function of cells called osteoclasts, which break down bone tissue. By blocking RANKL, denosumab reduces the activity of osteoclasts, which helps to:[4][6]

  • Increase bone density (make bones stronger)
  • Reduce the risk of fractures
  • Slow down bone damage in cancer patients
  • Inhibit the growth of certain bone tumors

How is Denosumab Administered?

Denosumab is typically administered as a subcutaneous injection, which means it’s injected under the skin. The dosage and frequency of administration can vary depending on the condition being treated:[1][2][3][4][5]

  • For osteoporosis: Usually 60 mg every 6 months
  • For cancer-related conditions: Often 120 mg every 4 weeks
  • For giant cell tumor of bone: 120 mg every 4 weeks, with additional doses on days 8 and 15 of the first month of treatment

The exact dosage and schedule will be determined by your healthcare provider based on your specific condition and needs.

Effectiveness of Denosumab

Clinical trials have shown that denosumab can be effective in treating various bone-related conditions:

  • In postmenopausal women with osteoporosis, denosumab has been shown to increase bone mineral density and reduce the risk of fractures[3]
  • For patients with multiple myeloma, denosumab can help reduce bone-related complications[4]
  • In patients with bone metastases from solid tumors, denosumab can help prevent skeletal-related events (such as fractures or need for radiation therapy)[5]
  • For giant cell tumor of bone, denosumab has shown promising results in reducing tumor size and potentially avoiding the need for extensive surgery[1]

Potential Side Effects

Like all medications, denosumab can cause side effects. Some potential side effects include:[1][2][5]

  • Hypocalcemia: Low levels of calcium in the blood
  • Osteonecrosis of the jaw: A rare but serious condition where the jaw bone is exposed and begins to starve from a lack of blood
  • Injection site reactions
  • Increased risk of infections
  • Muscle and joint pain

It’s important to discuss potential side effects with your healthcare provider and report any unusual symptoms you experience while taking denosumab.

Ongoing Research

Research on denosumab is ongoing to further understand its effects and explore its potential in treating other conditions. Some areas of current research include:

  • Comparing the effectiveness of denosumab to other treatments for bone metastases[5]
  • Investigating its use in children with osteogenesis imperfecta[6]
  • Studying different dosages and administration schedules to optimize treatment[3]
  • Evaluating its long-term safety and effectiveness[2]

As research continues, our understanding of denosumab and its potential uses may expand, potentially offering new treatment options for patients with bone-related conditions.

]]> Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins https://clinicaltrials.eu/drug/clostridium-botulinum-neurotoxin-type-a-150kd-free-of-complexing-proteins/ Wed, 01 Jul 2026 08:55:38 +0000 https://clinicaltrials.eu/drug/clostridium-botulinum-neurotoxin-type-a-150kd-free-of-complexing-proteins/ CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS: A Comprehensive Guide for Patients

Table of Contents

What is CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A?

CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS, also known as incobotulinumtoxinA or NT 201, is a purified form of botulinum toxin type A[1]. It is a neurotoxin produced by the bacterium Clostridium botulinum, but it has been refined for medical use. This particular formulation is free of complexing proteins, which means it contains only the active neurotoxin without additional bacterial proteins[2].

How does it work?

The neurotoxin works by temporarily blocking nerve signals to muscles, causing them to relax. Specifically, it prevents the release of a neurotransmitter called acetylcholine at the junction between nerves and muscles[3]. This mechanism of action makes it useful for treating various conditions characterized by muscle overactivity or spasms.

What medical conditions can it treat?

CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A is being studied for and used in the treatment of several medical conditions, including:

  • Diabetic neuropathic pain: It is being investigated for treating pain in the lower limbs caused by diabetic neuropathy[4].
  • Chronic neuropathic pain: Studies are exploring its use in treating chronic pain due to nerve damage or injury[5].
  • Overactive bladder (OAB): It’s being tested as a treatment for OAB symptoms in women[6].
  • Lower limb spasticity: The neurotoxin is used to treat muscle stiffness and spasms in the legs, particularly in patients who have had a stroke or traumatic brain injury[7].
  • Temporomandibular disorders: Research is ongoing into its effectiveness for jaw pain and dysfunction[8].
  • Incisional hernia treatment: It’s being studied as a pre-operative treatment to relax abdominal muscles before hernia repair surgery[9].

How is it administered?

The neurotoxin is typically administered through injection. The method of injection can vary depending on the condition being treated:

  • For diabetic neuropathic pain, it may be injected around nerves in the legs[4].
  • In OAB treatment, it can be injected into the bladder wall using a special delivery system[6].
  • For spasticity, it’s injected directly into the affected muscles[7].
  • In temporomandibular disorders, it may be injected into jaw muscles[8].

The dosage and frequency of administration can vary widely depending on the condition and individual patient factors. Always follow your healthcare provider’s instructions carefully.

How effective is it?

The effectiveness of CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A varies depending on the condition being treated. Clinical trials are ongoing to determine its efficacy for various uses. For example:

  • In lower limb spasticity, it has shown promise in reducing muscle stiffness and improving range of motion[7].
  • For overactive bladder, studies are investigating its potential to reduce urinary incontinence episodes and improve quality of life[6].
  • In neuropathic pain conditions, research is exploring its ability to reduce pain intensity and improve daily functioning[4][5].

What are the potential side effects?

As with any medical treatment, CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A can cause side effects. These can vary depending on the area of injection and the condition being treated. Some potential side effects include:

  • Muscle weakness near the injection site
  • Pain or bruising at the injection site
  • Headache
  • Fatigue
  • Flu-like symptoms

In rare cases, the toxin’s effects may spread beyond the injection site, potentially causing more serious side effects like difficulty swallowing or breathing. It’s crucial to report any unusual symptoms to your healthcare provider immediately[10].

Precautions and contraindications

CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A is not suitable for everyone. It should not be used in patients with:

  • Known allergies to botulinum toxin products
  • Infection at the proposed injection site
  • Certain neuromuscular disorders (e.g., myasthenia gravis)

Pregnant or breastfeeding women should consult their healthcare provider before using this treatment. Additionally, it may interact with certain medications, particularly those that affect neuromuscular function[11].

Ongoing research and future applications

Research into new applications for CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A is ongoing. Current areas of investigation include:

  • Its potential use in treating chronic migraine headaches
  • Applications in cosmetic procedures
  • Its role in managing various types of chronic pain

As research progresses, we may see this versatile neurotoxin being used to treat an even wider range of medical conditions in the future[12].

]]> Colecalciferol https://clinicaltrials.eu/drug/colecalciferol/ Wed, 01 Jul 2026 08:55:38 +0000 https://clinicaltrials.eu/drug/colecalciferol/ Colecalciferol (Vitamin D3): A Comprehensive Guide for Patients

Table of Contents

What is Colecalciferol?

Colecalciferol, also known as vitamin D3, is a form of vitamin D that is essential for human health[1]. It is naturally produced in our skin when exposed to sunlight and can also be obtained through diet or supplements. Colecalciferol is crucial for maintaining strong bones, regulating calcium and phosphate levels in the body, and supporting overall health[2].

Medical Uses

Colecalciferol is used to treat and prevent various health conditions related to vitamin D deficiency. Some of the main medical uses include:

  • Multiple Sclerosis (MS): Colecalciferol is being studied as an add-on treatment to interferon-beta-1b for patients with MS. Researchers believe it may help suppress clinical and MRI activity of the disease[1].
  • Inflammatory Bowel Diseases (IBD): Vitamin D supplementation is being investigated to determine the optimal dose for patients with IBD during winter months[2].
  • Chronic Kidney Disease: Colecalciferol is used to treat secondary hyperparathyroidism in patients with chronic kidney disease[3].
  • HIV Infection: Vitamin D supplementation is being studied to improve bone density, immune function, and adipocyte (fat cell) function in HIV-positive patients[4].
  • Uterine Fibroids: Research is ongoing to determine if vitamin D supplementation can inhibit the growth of uterine fibroids in women of reproductive age[5].
  • Epilepsy: Studies are being conducted to determine the appropriate maintenance dose of vitamin D for children with epilepsy to prevent vitamin D deficiency[7].

Dosage and Administration

The dosage of colecalciferol can vary depending on the condition being treated and the individual’s vitamin D status. Some common dosages observed in clinical trials include:

  • 20,000 IU (0.5 mg) once weekly for MS patients[1]
  • 1,600 IU daily for patients with vitamin D deficiency and uterine fibroids[5]
  • 800 IU daily for patients with vitamin D insufficiency and uterine fibroids[5]
  • 400 IU or 1000 IU daily for children with epilepsy[7]

It’s important to note that these dosages are from clinical trials and may not be appropriate for everyone. Always consult with your healthcare provider to determine the right dosage for your specific needs.

Benefits

Colecalciferol supplementation may offer several potential benefits, including:

  • Improved bone health and reduced risk of osteoporosis[4]
  • Enhanced immune function[3][4]
  • Potential reduction in MS disease activity[1]
  • Possible inhibition of uterine fibroid growth[5]
  • Improved vitamin D status in patients with various health conditions[2][7]

Side Effects and Safety

While colecalciferol is generally considered safe when taken as directed, some potential side effects and safety concerns include:

  • Hypercalcemia (high calcium levels in the blood)[5]
  • Abnormal liver function[5]
  • Urinary calculus (kidney stones)[5]
  • Abnormal renal function[5]

It’s important to monitor vitamin D levels, calcium levels, and other relevant markers when taking colecalciferol supplements, especially at higher doses or for extended periods.

Ongoing Research

Several clinical trials are currently investigating the effects of colecalciferol supplementation in various conditions:

  • Its potential as an add-on treatment for multiple sclerosis[1]
  • Optimal dosing for patients with inflammatory bowel diseases[2]
  • Effects on bone metabolism and immune system in dialysis patients[3]
  • Impact on HIV-positive patients’ bone density and immune function[4]
  • Potential to inhibit uterine fibroid growth[5]
  • Pharmacokinetics in healthy adults and those with intestinal malabsorption[8]
  • Effects of supplementation during pregnancy and lactation[9][10]

These ongoing studies aim to provide more insights into the potential benefits and optimal use of colecalciferol in various health conditions.

]]> Clodronate Disodium https://clinicaltrials.eu/drug/clodronate-disodium/ Wed, 01 Jul 2026 08:55:37 +0000 https://clinicaltrials.eu/drug/clodronate-disodium/ Clodronate Disodium: A Comprehensive Guide for Patients

Table of Contents

What is Clodronate?

Clodronate disodium, also known by brand names such as Bonefos, is a medication that belongs to a class of drugs called bisphosphonates[1]. Bisphosphonates are medications that help prevent the breakdown of bones. Clodronate works by reducing the activity of cells called osteoclasts, which are responsible for breaking down bone tissue[1].

Uses of Clodronate

Clodronate is used to treat several conditions related to bone health:

  • Postmenopausal Osteoporosis: This is a condition where bones become weak and fragile after menopause, increasing the risk of fractures[1].
  • Bone Metastases: These are cancerous tumors that have spread from their original site to the bones. Clodronate is used in patients with bone metastases from breast cancer, prostate cancer, and multiple myeloma (a type of blood cancer that affects bone marrow)[2].
  • Pain Management: Clodronate has been associated with improvements in back pain in patients with osteoporosis and can help reduce pain in patients with bone metastases[1][3].

How Clodronate is Administered

Clodronate can be administered in several ways:

  • Oral tablets: Taken daily for extended periods, often for several months or years[2].
  • Intramuscular injections: Given into a muscle, typically every 1-2 weeks[1].
  • Intravenous infusions: Administered directly into a vein, though this is less common than oral or intramuscular routes[1].

The specific dosage and administration method will depend on the condition being treated and the patient’s individual needs. It’s important to follow your doctor’s instructions carefully when taking clodronate.

Effectiveness of Clodronate

Research has shown that clodronate can be effective in several ways:

  • Preventing bone loss: Clodronate helps maintain bone density, which is particularly important in postmenopausal women with osteoporosis[1].
  • Reducing fracture risk: By strengthening bones, clodronate can help reduce the risk of fractures in people with osteoporosis[1].
  • Pain relief: Many patients experience a reduction in bone pain when taking clodronate, particularly those with bone metastases[3].
  • Preventing skeletal-related events: In cancer patients with bone metastases, clodronate may help prevent complications such as fractures or the need for radiation therapy to the bones[2].

Potential Side Effects

While clodronate is generally well-tolerated, it can cause some side effects. These may include:

  • Gastrointestinal issues: Such as nausea, diarrhea, or stomach discomfort. These are more common with oral forms of the medication[1].
  • Flu-like symptoms: Some patients may experience fever, chills, or muscle aches, particularly after the first dose.
  • Injection site reactions: For intramuscular injections, there may be some pain or irritation at the injection site[1].

It’s important to discuss any side effects with your healthcare provider. They can help manage these effects or adjust your treatment if necessary.

Ongoing Research

Researchers continue to study clodronate to better understand its effects and potential uses. Some areas of ongoing research include:

  • Optimal dosing: Studies are investigating different doses and administration schedules to find the most effective and convenient regimens for patients[1].
  • Use in cancer treatment: Researchers are studying whether clodronate can help prevent cancer from spreading to the bones in patients with early-stage breast cancer[4].
  • Combination with other treatments: Studies are looking at how clodronate works when combined with other cancer treatments like chemotherapy or hormonal therapy[4].
  • Long-term effects: Researchers are investigating the long-term benefits and potential risks of clodronate use[5].

As research continues, we may learn more about how to use clodronate most effectively to improve bone health and quality of life for patients with various bone-related conditions.

]]> Clonidine Hydrochloride https://clinicaltrials.eu/drug/clonidine-hydrochloride/ Wed, 01 Jul 2026 08:55:37 +0000 https://clinicaltrials.eu/drug/clonidine-hydrochloride/ Clonidine Hydrochloride: A Comprehensive Guide for Patients

Table of Contents

What is Clonidine Hydrochloride?

Clonidine Hydrochloride, also known by brand names such as Kapvay, Catapres, Duraclon, and Nexiclon, is a medication that belongs to a class of drugs called alpha-2 adrenergic agonists[1]. This means it works by stimulating certain receptors in the brain and body that help regulate various functions, including blood pressure, pain sensation, and certain behaviors[2].

Medical Uses of Clonidine

Clonidine Hydrochloride is used to treat several medical conditions:

  • Attention Deficit Hyperactivity Disorder (ADHD): Clonidine can help manage symptoms of ADHD in children and adolescents[3].
  • Hypertension: It’s used to treat high blood pressure, particularly in postpartum women with hypertensive disorders of pregnancy[4].
  • Pain Management: Clonidine can be used to manage certain types of pain, including painful diabetic neuropathy (nerve pain caused by diabetes)[1].
  • Opioid Withdrawal: It’s used to help treat withdrawal symptoms in infants born to mothers who used opioids during pregnancy, a condition known as Neonatal Abstinence Syndrome[5].
  • Anesthesia: Clonidine can be used as part of anesthesia procedures to help with pain control and sedation[2].

How Clonidine is Administered

Clonidine can be given in several ways, depending on the condition being treated:

  • Oral tablets: For conditions like ADHD, clonidine is often given as a pill to be taken by mouth[3].
  • Topical gel: For pain management, such as in diabetic neuropathy, clonidine may be applied as a gel directly to the skin[1].
  • Injections: In some medical procedures, clonidine can be injected into the space around the spinal cord (epidural space) or into specific areas of the body for pain control[2].
  • Transdermal patch: Some forms of clonidine can be administered through a patch placed on the skin[6].

Effectiveness of Clonidine

Research has shown that clonidine can be effective for its various uses:

  • In children with ADHD, clonidine has been shown to help maintain improvement in symptoms over long periods[3].
  • For pain management, studies have found that clonidine can help reduce pain intensity in conditions like diabetic neuropathy[1].
  • In treating neonatal abstinence syndrome, clonidine has shown promise in reducing the severity of withdrawal symptoms and the time needed for treatment[7].

Potential Side Effects

Like all medications, clonidine can cause side effects. Some potential side effects include:

  • Drowsiness or sedation: Clonidine can make you feel sleepy or tired[3].
  • Changes in blood pressure: It may cause your blood pressure to drop, especially when you first start taking it[6].
  • Dry mouth
  • Dizziness
  • Constipation

It’s important to discuss any side effects with your healthcare provider. They can help determine if the benefits of the medication outweigh the risks for your specific situation.

Ongoing Research and Future Prospects

Researchers continue to study clonidine to better understand its effects and potential new uses:

  • Studies are looking at the use of clonidine in combination with other medications for pain management during and after surgery[2].
  • Research is ongoing to determine the best ways to use clonidine for treating opioid withdrawal in infants[7].
  • Scientists are investigating the potential of clonidine to reduce heart-related complications after non-cardiac surgery[6].

As with any medication, it’s crucial to take clonidine only as prescribed by your healthcare provider. They can provide personalized advice based on your specific medical condition and overall health status.

]]> Celecoxib https://clinicaltrials.eu/drug/celecoxib/ Wed, 01 Jul 2026 08:55:32 +0000 https://clinicaltrials.eu/drug/celecoxib/ Celecoxib: A Comprehensive Guide for Patients

Table of Contents

What is Celecoxib?

Celecoxib is a medication that belongs to a class of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). It is specifically known as a selective COX-2 inhibitor, which means it targets a specific enzyme in the body responsible for inflammation and pain[1]. Celecoxib is sold under various brand names, including:

  • Celebrex
  • Celebra
  • Celcox
  • MINT-CELECOXIB

It is available in different forms, including capsules and liquid suspensions, and is typically taken orally (by mouth)[2].

How Does Celecoxib Work?

Celecoxib works by inhibiting an enzyme called cyclooxygenase-2 (COX-2). This enzyme is responsible for producing prostaglandins, which are substances in the body that cause inflammation, pain, and fever. By blocking COX-2, Celecoxib reduces inflammation and pain without affecting the protective COX-1 enzyme found in the stomach and intestines[3].

This selective action is what sets Celecoxib apart from traditional NSAIDs like ibuprofen or naproxen, which inhibit both COX-1 and COX-2 enzymes. The selectivity of Celecoxib may result in fewer gastrointestinal side effects compared to non-selective NSAIDs[4].

Conditions Treated with Celecoxib

Celecoxib is used to treat various conditions characterized by pain and inflammation. Based on the clinical trials information provided, Celecoxib has been studied for use in the following conditions:

  1. Osteoarthritis: This is a common form of arthritis where the cartilage that cushions the bones wears down over time, causing pain and stiffness in joints[5].
  2. Rheumatoid Arthritis: An autoimmune disorder that causes inflammation in the joints, leading to pain, swelling, and potential joint damage[6].
  3. Acute Pain: Such as pain following dental procedures or surgery[7].
  4. Colorectal Cancer: Some studies are investigating the potential use of Celecoxib in preventing or treating certain types of colorectal cancer, particularly in high-risk individuals[8].
  5. Obsessive-Compulsive Disorder (OCD): Research is being conducted to explore the potential benefits of Celecoxib as an add-on treatment for OCD in children and adolescents[9].
  6. Head and Neck Cancer: Studies are investigating the use of Celecoxib alongside chemotherapy and radiation therapy for advanced head and neck cancers[10].

Dosage and Administration

The dosage of Celecoxib can vary depending on the condition being treated, the patient’s age, weight, and other factors. Based on the clinical trials information, some common dosages include:

  • For osteoarthritis: 200 mg once daily or 100 mg twice daily[11]
  • For acute pain: 400 mg initially, followed by 200 mg twice daily as needed[12]
  • For children with OCD: 50 mg or 100 mg twice daily, based on weight[13]

It’s important to note that these dosages are examples from clinical trials and may not reflect the dosage your doctor prescribes. Always follow your healthcare provider’s instructions regarding dosage and administration.

Potential Side Effects

Like all medications, Celecoxib can cause side effects. Some potential side effects observed in clinical trials include:

  • Gastrointestinal issues (such as stomach upset or nausea)
  • Headache
  • Dizziness
  • Skin rash
  • Increased risk of cardiovascular events (in some patients with pre-existing conditions)

It’s important to discuss potential side effects with your healthcare provider before starting Celecoxib. They can provide more detailed information based on your individual health status and medical history[14].

Ongoing Research and Potential New Uses

Researchers are continually studying Celecoxib to understand its full potential. Some areas of ongoing research include:

  1. Cancer Prevention and Treatment: Studies are exploring whether Celecoxib could help prevent certain types of cancer or enhance the effectiveness of cancer treatments[15].
  2. Mental Health Conditions: Research is being conducted on the potential use of Celecoxib as an add-on treatment for conditions like obsessive-compulsive disorder[16].
  3. Combination Therapies: Scientists are investigating how Celecoxib might work in combination with other medications to treat various conditions more effectively[17].

It’s important to note that these are areas of ongoing research, and Celecoxib may not be approved for these uses. Always consult with your healthcare provider about the most current and appropriate treatments for your specific condition.

]]> Capivasertib https://clinicaltrials.eu/drug/capivasertib/ Wed, 01 Jul 2026 08:55:30 +0000 https://clinicaltrials.eu/drug/capivasertib/ Capivasertib: A Promising Treatment for Various Cancers

Table of Contents

What is Capivasertib?

Capivasertib, also known as AZD5363 or Truqap, is a promising new drug being studied for the treatment of various types of cancer[1]. It is a type of medication called a kinase inhibitor, which means it works by blocking certain proteins in cancer cells that help them grow and survive[2].

How Capivasertib Works

Capivasertib specifically targets and inhibits a protein called AKT (also known as protein kinase B). AKT is an important part of a signaling pathway in cells that can become overactive in cancer, leading to uncontrolled cell growth and survival. By blocking AKT, capivasertib aims to slow down or stop the growth of cancer cells[1][3].

Cancers Treated with Capivasertib

Capivasertib is being studied in clinical trials for several types of cancer, including:

  • Breast cancer: Particularly for patients with hormone receptor-positive (HR+) and HER2-negative breast cancer, as well as triple-negative breast cancer (TNBC)[3][4]
  • Prostate cancer: Specifically for patients with metastatic castration-resistant prostate cancer (CRPC)[5]
  • Lymphoma: Including various types of B-cell non-Hodgkin lymphoma[2]
  • Other solid tumors: Capivasertib is being investigated in patients with various advanced solid tumors[6]

Clinical Trials and Research

Capivasertib is currently being studied in several clinical trials to determine its effectiveness and safety. Some key areas of research include:

  • Combination therapy: Capivasertib is being tested in combination with other cancer treatments, such as hormone therapies (fulvestrant) for breast cancer and chemotherapy (paclitaxel) for triple-negative breast cancer[7][4]
  • Biomarker studies: Researchers are looking at whether certain genetic changes in tumors, such as AKT mutations, can predict which patients will respond best to capivasertib[1]
  • Early detection of cancer recurrence: One study is investigating whether capivasertib can help prevent cancer recurrence in patients who have detectable cancer DNA in their blood after initial treatment[3]

Administration and Dosing

Capivasertib is typically given as an oral medication (taken by mouth) in the form of tablets. The dosing schedule can vary depending on the specific clinical trial and cancer type, but common schedules include:

  • Taking the medication twice daily for 4 days, followed by 3 days off[2]
  • Taking the medication twice daily for 4 days each week, with 3 days off, as part of a 28-day cycle[4]

The exact dose may be adjusted based on how well a patient tolerates the medication and their individual response to treatment.

Side Effects and Safety

As with all cancer treatments, capivasertib can cause side effects. While the full safety profile is still being studied in clinical trials, some potential side effects may include:

  • Fatigue
  • Nausea
  • Diarrhea
  • Changes in blood sugar levels
  • Skin rash

It’s important to note that not all patients will experience these side effects, and the severity can vary. Researchers are closely monitoring the safety and tolerability of capivasertib in ongoing clinical trials[8].

Future Prospects

Capivasertib shows promise in the treatment of various cancers, particularly in combination with other therapies. Ongoing research aims to:

  • Determine the most effective dosing schedules and combinations with other treatments
  • Identify which patients are most likely to benefit from capivasertib based on genetic markers in their tumors
  • Explore its potential in preventing cancer recurrence in high-risk patients

As clinical trials progress, more information will become available about the effectiveness and safety of capivasertib in different cancer types and treatment settings[3][4].

]]> Capsaicin https://clinicaltrials.eu/drug/capsaicin/ Wed, 01 Jul 2026 08:55:30 +0000 https://clinicaltrials.eu/drug/capsaicin/ Capsaicin: A Versatile Treatment for Various Conditions

Table of Contents

What is Capsaicin?

Capsaicin is a natural compound found in chili peppers that is known for its pain-relieving properties. It is the active ingredient in various medical treatments, particularly for managing different types of pain. Capsaicin works by desensitizing pain receptors in the skin, which can lead to a reduction in pain sensations[1]. This compound is also known by its chemical name, 8-Methyl-N-vanillyl-trans-6-nonenamide[2].

Conditions Treated with Capsaicin

Capsaicin is used to treat various conditions, including:

  • Neuropathic pain: This is pain caused by damage or dysfunction of the nervous system. Capsaicin has shown effectiveness in treating neuropathic pain associated with conditions such as:
    • Diabetic neuropathy (nerve pain related to diabetes)[3]
    • Post-herpetic neuralgia (pain following shingles)[4]
    • HIV-associated neuropathy[4]
  • Coccygodynia: This is pain in the tailbone area. Capsaicin is being studied for its potential to relieve this type of pain[5].
  • Critical ischemia in end-stage renal failure: This is a condition where there is severe pain due to poor blood flow in patients with kidney failure. Capsaicin is being investigated as a treatment option for this difficult-to-manage pain[4].
  • Pain associated with lower limb amputation: Capsaicin is being studied for its potential to prevent neuropathic pain following limb amputation[1].

Forms and Applications of Capsaicin

Capsaicin is available in various forms for medical use:

  • Topical patches: One of the most common forms is the Qutenza patch, which contains 8% capsaicin. This patch is applied to the skin for a specific duration, typically 30-60 minutes, depending on the condition being treated[6].
  • Creams and gels: Capsaicin is also available in lower concentrations (e.g., 0.075%) as creams or gels that can be applied directly to the skin[3].
  • Topical solutions: Some formulations come as topical solutions that can be applied using a roll-on applicator[3].

Effectiveness of Capsaicin

Studies have shown that capsaicin can be effective in reducing pain for various conditions:

  • In neuropathic pain conditions, capsaicin patches have demonstrated significant pain reduction lasting up to 12 weeks after a single application[4].
  • For diabetic neuropathy, one study found a 31.5% reduction in mean pain scores during weeks 2-12 post-treatment[4].
  • In studies of post-herpetic neuralgia and HIV neuropathy, pain reduction ranged from 30-32% compared to 20-24% with a lower concentration control[4].

Side Effects and Tolerability

While capsaicin is generally well-tolerated, it can cause some side effects, particularly at the application site:

  • Common side effects include temporary burning, redness, or itching at the application site[4].
  • More severe side effects like blistering are rare, occurring in less than 5% of cases[4].
  • Patients with diabetes should be monitored closely, as there is a slight risk of skin ulceration[4].

Ongoing Research and Potential Uses

Researchers are exploring new potential uses for capsaicin:

  • Chest pain perception: Studies are investigating whether capsaicin sensitivity could be used to assess an individual’s ability to perceive chest pain related to heart problems[7].
  • Cerebral blood flow: Research is being conducted to determine if capsaicin can increase blood flow to the brain, which could have implications for treating certain neurological conditions[2].
  • Pain management in pulmonary arterial hypertension: Capsaicin is being studied as a potential treatment for pain associated with subcutaneous infusion of treprostinil, a medication used for pulmonary arterial hypertension[8].
]]> Calcium Carbonate https://clinicaltrials.eu/drug/calcium-carbonate/ Wed, 01 Jul 2026 08:55:29 +0000 https://clinicaltrials.eu/drug/calcium-carbonate/ Calcium Carbonate: A Comprehensive Guide for Patients

Table of Contents

What is Calcium Carbonate?

Calcium carbonate is a common medication used to supplement calcium in the body. It’s often known by brand names such as Tums[1]. This compound contains a high concentration of elemental calcium, specifically 42% per gram, making it an efficient source of calcium supplementation[2].

Medical Uses of Calcium Carbonate

Calcium carbonate is used to treat or prevent various medical conditions:

  • Chronic Kidney Disease (CKD): It’s used to manage high phosphate levels (hyperphosphatemia) in patients with CKD, especially those on dialysis[3].
  • Hypoparathyroidism: This condition occurs when the body doesn’t produce enough parathyroid hormone, leading to low calcium levels. Calcium carbonate is used to manage this condition[2].
  • Osteoporosis Prevention: It’s used to prevent bone loss in conditions like osteoporosis[4].
  • Vitamin D Deficiency: Often combined with vitamin D supplements to improve calcium absorption[5].
  • Postpartum Hemorrhage Prevention: Research is being conducted to investigate if calcium carbonate can help reduce bleeding after childbirth[1].

Dosage and Administration

The dosage of calcium carbonate can vary depending on the condition being treated and the patient’s specific needs. Here are some examples from clinical trials:

  • For hyperphosphatemia in CKD: Doses ranged from 3000 mg to 6500 mg per day, divided into three doses taken with meals[3].
  • For hypoparathyroidism: Doses of 1500 mg to 3000 mg per day, divided into two doses[2].
  • For vitamin D supplementation after parathyroid surgery: 1000 mg per day, divided into two 500 mg doses[5].

It’s important to note that calcium carbonate is typically taken with food to improve absorption. Always follow your doctor’s instructions regarding dosage and timing of medication[2].

Comparison with Other Medications

Calcium carbonate is often compared to other medications used for similar purposes:

  • Lanthanum Carbonate: This is another phosphate binder used in CKD. Some studies suggest it may have benefits over calcium carbonate in terms of cardiovascular outcomes and bone health[6].
  • Sevelamer Carbonate: This non-calcium-based phosphate binder may have advantages in terms of reducing inflammation and oxidative stress in diabetic patients with kidney disease[7].
  • Calcium Citrate: This form of calcium may be better absorbed in certain conditions, such as achlorhydria (lack of stomach acid) or in patients taking proton pump inhibitors[2].

Side Effects and Precautions

While calcium carbonate is generally well-tolerated, it can cause some side effects:

  • Gastrointestinal Issues: It may cause flatulence, constipation, and general gastrointestinal discomfort[2].
  • Kidney Stones: Long-term use of high doses may increase the risk of kidney stones in some patients[2].
  • Hypercalcemia: Excessive intake can lead to high blood calcium levels, which can be harmful[4].

Patients with certain conditions, such as kidney problems or a history of kidney stones, should use calcium carbonate under close medical supervision[2].

Ongoing Research

Several clinical trials are currently investigating the use of calcium carbonate in various conditions:

  • Its potential role in reducing postpartum hemorrhage[1].
  • Comparison with other phosphate binders in terms of long-term cardiovascular outcomes in dialysis patients[6].
  • Its effectiveness when combined with vitamin D supplementation after parathyroid surgery[5].

These ongoing studies aim to further our understanding of calcium carbonate’s benefits and potential risks in different patient populations.

]]>